data_1iwf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1iwf _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.454 ' HB3' ' HB2' ' A' ' 9' ' ' LEU . 3.6 t-20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.266 0.555 . . . . 0.0 109.58 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -92.26 -55.43 3.42 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.333 -0.854 . . . . 0.0 109.363 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -127.91 53.14 1.8 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.387 -0.821 . . . . 0.0 109.57 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 10' ' ' TYR . 3.5 tm? -88.97 -71.36 0.6 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 109.442 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.542 ' CD1' ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -76.42 4.18 9.59 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.301 -0.874 . . . . 0.0 110.333 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.06 32.67 0.74 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.49 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 2.3 p -105.95 68.95 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.698 -0.626 . . . . 0.0 109.524 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 49.74 55.77 8.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.329 -0.857 . . . . 0.0 109.429 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.414 HD12 ' HB2' ' A' ' 10' ' ' TYR . 0.8 OUTLIER -56.04 173.23 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 109.414 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 14' ' ' LEU . . . 55.29 100.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.91 78.49 3.55 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.425 2.083 . . . . 0.0 110.291 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.51 80.06 0.34 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.26 -81.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.671 2.247 . . . . 0.0 110.43 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.4 t -57.54 132.51 53.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 109.612 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.95 -147.45 49.46 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.305 -1.115 . . . . 0.0 109.517 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -98.48 -25.76 14.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.458 -0.776 . . . . 0.0 109.408 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -91.3 47.23 1.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.14 -0.975 . . . . 0.0 109.576 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.7 tt -82.04 -19.93 39.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.161 -0.962 . . . . 0.0 109.439 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.409 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -80.92 6.6 12.8 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.228 -0.92 . . . . 0.0 109.504 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.42 34.7 0.95 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.455 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 2.2 p -101.54 71.29 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.832 -0.542 . . . . 0.0 109.603 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 14' ' ' LEU . 1.3 tt0 54.75 46.38 24.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.314 -0.866 . . . . 0.0 109.534 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.8 OUTLIER -46.15 171.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 109.336 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.09 137.76 41.09 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.29 78.97 3.43 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.436 2.09 . . . . 0.0 110.521 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.51 178.04 16.63 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.413 ' C ' ' OG ' ' A' ' 19' ' ' SER . 35.9 Cg_endo -78.6 -58.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.662 2.242 . . . . 0.0 110.408 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.413 ' OG ' ' C ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER 62.84 35.46 13.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -0.95 . . . . 0.0 109.369 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.84 -108.82 3.28 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.228 -1.16 . . . . 0.0 109.461 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.8 m120 . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.28 -34.77 17.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.347 -0.846 . . . . 0.0 109.144 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.45 ' OE1' ' OE1' ' A' ' 11' ' ' GLN . 2.2 mt-10 -88.63 38.98 0.9 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.415 -0.803 . . . . 0.0 109.534 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.471 ' C ' ' CD1' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -71.18 -58.48 3.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -0.946 . . . . 0.0 109.232 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.518 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -82.88 7.21 15.95 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.221 -0.925 . . . . 0.0 109.387 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.45 ' OE1' ' OE1' ' A' ' 8' ' ' GLU . 4.8 tt0 -89.86 36.94 0.86 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.965 . . . . 0.0 108.415 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 12' ' ' VAL . 2.9 p -110.59 79.99 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.725 -0.609 . . . . 0.0 109.603 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 14' ' ' LEU . 1.1 tt0 50.11 71.23 0.42 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.083 -1.01 . . . . 0.0 108.821 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.498 ' CD2' ' O ' ' A' ' 10' ' ' TYR . 0.9 OUTLIER -42.27 161.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.339 -0.851 . . . . 0.0 109.71 -179.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.04 -67.07 0.04 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.15 74.44 5.32 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.657 2.238 . . . . 0.0 110.255 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.75 155.27 20.79 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -80.58 42.87 1.41 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.775 2.317 . . . . 0.0 110.592 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.0 p -59.61 123.2 16.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 109.553 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.3 -141.34 6.24 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.255 -1.144 . . . . 0.0 109.466 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.387 0.613 . . . . 0.0 109.539 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.509 ' N ' ' CD1' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -89.5 -63.87 1.22 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.279 -0.888 . . . . 0.0 109.423 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 7' ' ' TYR . 11.8 mt-10 64.12 65.25 0.69 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.435 -0.79 . . . . 0.0 109.391 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 tt -120.19 -47.61 2.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.184 -0.947 . . . . 0.0 109.329 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -84.34 10.82 9.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.276 -0.89 . . . . 0.0 109.268 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.97 32.89 0.88 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 12' ' ' VAL . 3.7 p -109.96 76.63 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 121.383 0.611 . . . . 0.0 109.457 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 51.93 63.6 2.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.119 -0.988 . . . . 0.0 109.284 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 10' ' ' TYR . 5.1 mt -45.64 165.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.351 -0.843 . . . . 0.0 109.659 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.2 -90.8 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.61 -164.87 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.804 2.336 . . . . 0.0 110.45 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.36 -94.96 0.15 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.85 -24.97 8.09 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.53 2.153 . . . . 0.0 110.507 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.01 -168.32 1.88 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.31 -0.869 . . . . 0.0 109.476 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 21' ' ' ASP . . . -68.09 -101.41 0.03 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.502 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 15.8 t70 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.286 -1.126 . . . . 0.0 109.545 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 7' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.169 0.509 . . . . 0.0 109.774 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.473 ' O ' ' O ' ' A' ' 6' ' ' ASN . 2.6 m-85 -40.81 165.48 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.243 -0.911 . . . . 0.0 110.712 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 7' ' ' TYR . 0.8 OUTLIER -157.04 -101.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.54 -0.725 . . . . 0.0 109.537 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.483 ' O ' HG11 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -127.69 -131.22 0.23 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.956 -1.09 . . . . 0.0 108.827 -179.721 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.56 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -68.01 -1.66 6.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.686 -1.259 . . . . 0.0 110.616 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.417 ' N ' ' HD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -91.49 32.01 1.11 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.792 -1.193 . . . . 0.0 108.166 179.19 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 12' ' ' VAL . 3.1 p -105.72 98.97 7.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 121.299 0.571 . . . . 0.0 109.78 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER 48.54 31.05 2.69 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.164 -0.96 . . . . 0.0 109.405 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.528 ' N ' HD21 ' A' ' 14' ' ' LEU . 0.6 OUTLIER -50.24 179.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.286 -0.884 . . . . 0.0 109.701 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -123.8 -76.45 0.32 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -76.87 80.48 2.82 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.652 2.234 . . . . 0.0 110.627 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -103.81 -149.77 20.76 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.06 -34.11 1.81 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.411 2.074 . . . . 0.0 110.087 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -122.24 165.87 15.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.366 -0.834 . . . . 0.0 109.189 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.43 -97.14 0.89 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.24 -1.153 . . . . 0.0 109.893 -179.672 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.0 t30 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -96.03 -78.79 0.45 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.39 -0.819 . . . . 0.0 109.31 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 7' ' ' TYR . 18.2 mt-10 42.12 44.55 3.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 109.705 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' A' ' 10' ' ' TYR . 10.2 tt -67.33 -86.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.416 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.551 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -74.88 3.72 7.7 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.912 -1.117 . . . . 0.0 110.531 -179.77 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.4 ' N ' ' HD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -93.58 32.63 1.36 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.019 -1.051 . . . . 0.0 108.187 179.139 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 12' ' ' VAL . 2.4 p -101.98 87.19 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.66 -0.65 . . . . 0.0 110.008 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 12' ' ' VAL . 16.4 mm-40 44.54 48.45 8.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.135 -0.978 . . . . 0.0 109.349 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 10' ' ' TYR . 1.7 mt -47.48 151.4 0.79 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.386 -0.821 . . . . 0.0 109.514 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -109.56 156.83 15.42 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.9 82.46 2.42 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.641 2.227 . . . . 0.0 110.491 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.91 167.12 22.4 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.49 -41.21 0.27 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.606 2.204 . . . . 0.0 110.452 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.7 t -84.21 149.55 26.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -0.85 . . . . 0.0 109.478 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 21' ' ' ASP . . . -164.06 -162.83 15.7 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.44 ' O ' ' O ' ' A' ' 20' ' ' GLY . 8.3 m-20 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.254 -1.145 . . . . 0.0 109.45 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.522 ' O ' ' CB ' ' A' ' 11' ' ' GLN . 1.2 m120 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.299 0.571 . . . . 0.0 109.807 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.59 -30.46 16.36 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.178 -0.951 . . . . 0.0 109.137 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -113.3 15.63 19.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.326 -0.859 . . . . 0.0 109.879 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.521 ' CB ' ' HB3' ' A' ' 6' ' ' ASN . 0.2 OUTLIER -104.84 -142.24 0.37 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.021 -1.049 . . . . 0.0 109.266 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.51 ' CE1' HD21 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -65.0 -6.19 8.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.111 -0.993 . . . . 0.0 110.47 -179.553 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.522 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 1.0 OUTLIER -90.4 40.39 1.01 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.957 -1.089 . . . . 0.0 108.126 179.254 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 12' ' ' VAL . 2.8 p -113.31 85.62 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.783 -0.573 . . . . 0.0 109.754 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER 45.44 75.77 0.1 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.005 -1.059 . . . . 0.0 108.951 -179.607 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 13' ' ' GLU . 3.4 mm? -44.2 169.07 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.362 -0.836 . . . . 0.0 109.689 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.01 176.6 23.97 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.48 86.66 1.64 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.612 2.208 . . . . 0.0 110.532 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 61.15 86.69 0.04 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.19 -70.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.617 2.211 . . . . 0.0 110.512 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.433 ' O ' ' OG ' ' A' ' 19' ' ' SER . 26.3 p -175.37 93.91 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.136 -0.978 . . . . 0.0 109.659 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 142.64 -132.92 5.32 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.2 p30 . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.203 -1.175 . . . . 0.0 109.528 -179.964 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.329 0.585 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.91 -66.74 0.85 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 109.23 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 45.89 72.52 0.22 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.485 -0.76 . . . . 0.0 109.453 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.47 -139.37 0.27 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.889 . . . . 0.0 109.147 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.529 ' CD1' ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -68.63 -2.67 9.6 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.942 -1.099 . . . . 0.0 110.499 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.478 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.9 OUTLIER -90.28 34.05 0.88 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.229 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 12' ' ' VAL . 3.4 p -103.77 78.02 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.355 0.597 . . . . 0.0 109.496 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER 56.41 64.99 1.53 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.074 -1.016 . . . . 0.0 108.816 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -48.52 -179.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.411 -0.805 . . . . 0.0 109.862 -179.542 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -169.48 94.68 0.11 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.03 86.79 1.64 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.638 2.225 . . . . 0.0 110.944 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.9 77.92 1.38 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.59 -63.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.692 2.261 . . . . 0.0 110.549 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.27 116.14 12.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 109.903 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.34 179.37 2.99 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.259 -1.142 . . . . 0.0 109.376 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.591 ' N ' ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -93.04 -30.73 15.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 0.0 109.369 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 67.19 59.44 0.53 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.48 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 tt -71.28 -7.25 45.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.635 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -88.31 -5.08 58.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.18 -0.95 . . . . 0.0 109.399 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.66 41.06 1.02 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 12' ' ' VAL . 2.7 p -112.93 93.89 2.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.708 -0.62 . . . . 0.0 109.925 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 12' ' ' VAL . 8.6 tp10 44.47 51.38 7.87 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.11 -0.994 . . . . 0.0 109.248 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 10' ' ' TYR . 1.4 mt -55.7 -179.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.353 -0.842 . . . . 0.0 109.631 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.71 -64.42 0.17 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.27 81.38 2.64 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.646 2.231 . . . . 0.0 110.285 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.71 -173.6 7.05 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.32 -63.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.663 2.242 . . . . 0.0 110.495 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 71.2 p -125.36 24.35 7.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.262 -0.899 . . . . 0.0 109.572 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.56 -148.82 14.49 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.252 -1.146 . . . . 0.0 109.423 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.25 -67.64 0.77 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.139 -0.976 . . . . 0.0 109.431 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.438 ' OE2' HG21 ' A' ' 12' ' ' VAL . 1.8 mt-10 52.4 74.87 0.25 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.397 -0.815 . . . . 0.0 109.207 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.541 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -90.97 -145.52 0.19 Allowed 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.135 -0.978 . . . . 0.0 109.364 -179.742 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.541 ' N ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -70.59 -1.98 12.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.137 -0.977 . . . . 0.0 110.342 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.408 ' N ' ' HD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -94.14 31.6 1.65 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.132 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.491 HG11 ' O ' ' A' ' 9' ' ' LEU . 2.6 p -96.97 75.91 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 14' ' ' LEU . 1.0 OUTLIER 47.19 53.04 11.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.17 -0.956 . . . . 0.0 109.213 -179.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.542 ' N ' HD21 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -48.26 178.13 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.392 -0.817 . . . . 0.0 110.004 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.2 -78.85 0.09 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -80.8 -165.33 0.33 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.731 2.287 . . . . 0.0 110.746 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -166.31 -156.28 9.4 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.66 -9.69 15.86 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.62 2.213 . . . . 0.0 110.48 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.49 -92.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 109.581 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 21' ' ' ASP . . . -104.78 -159.2 23.65 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 1.6 m-20 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.278 -1.131 . . . . 0.0 109.512 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 m120 . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.233 0.539 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.1 -47.99 9.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.015 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.433 ' HA ' ' OE1' ' A' ' 8' ' ' GLU . 4.2 mm-40 -106.42 65.43 0.68 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.469 -0.769 . . . . 0.0 109.276 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 tt -86.04 8.98 18.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 109.493 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.548 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -87.41 -8.01 57.05 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.317 -0.864 . . . . 0.0 109.63 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.12 40.06 0.99 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 12' ' ' VAL . 2.2 p -106.63 75.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.392 0.615 . . . . 0.0 109.96 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 12' ' ' VAL . 60.7 mt-10 43.9 44.0 5.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.289 -0.882 . . . . 0.0 109.591 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.519 ' CD2' ' N ' ' A' ' 15' ' ' GLY . 5.2 tt -47.8 153.07 0.65 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.27 -0.894 . . . . 0.0 109.427 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.519 ' N ' ' CD2' ' A' ' 14' ' ' LEU . . . 165.6 168.32 27.59 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.3 81.27 2.78 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.758 2.305 . . . . 0.0 110.415 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.32 174.58 3.61 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.74 -3.16 13.28 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.549 2.166 . . . . 0.0 110.321 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.7 m -135.75 163.63 29.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.241 -0.912 . . . . 0.0 109.409 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.79 -151.99 23.65 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.8 t70 . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.274 -1.133 . . . . 0.0 109.351 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.11 -51.21 4.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.12 -0.987 . . . . 0.0 109.852 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -94.54 25.68 3.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.289 -0.882 . . . . 0.0 109.998 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 tt -72.86 -48.99 32.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.072 -1.017 . . . . 0.0 109.351 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.531 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -75.99 -5.52 46.69 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.279 -0.888 . . . . 0.0 109.757 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -88.32 43.96 1.17 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 12' ' ' VAL . 3.5 p -116.96 78.85 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 121.376 0.608 . . . . 0.0 109.633 -178.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 50.37 74.66 0.21 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.106 -0.996 . . . . 0.0 109.14 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 10' ' ' TYR . 3.9 mm? -49.78 140.67 11.24 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.294 -0.879 . . . . 0.0 109.395 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.04 -94.64 0.49 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.54 75.27 5.04 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.651 2.234 . . . . 0.0 110.51 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.72 -157.32 32.61 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.4 -19.16 11.91 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.61 2.206 . . . . 0.0 110.419 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.9 p -102.24 80.18 1.94 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.286 -0.884 . . . . 0.0 109.457 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -156.56 -64.65 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 38.3 p-10 . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.346 -1.091 . . . . 0.0 109.54 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.408 ' OD1' ' HG2' ' A' ' 8' ' ' GLU . 21.6 t-20 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.405 ' O ' ' C ' ' A' ' 8' ' ' GLU . 0.1 OUTLIER -77.73 -46.03 22.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.151 -0.968 . . . . 0.0 108.786 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.408 ' HG2' ' OD1' ' A' ' 6' ' ' ASN . 0.2 OUTLIER 45.28 36.17 2.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.404 -0.81 . . . . 0.0 109.361 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.457 ' HB3' ' CD1' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -103.97 -58.52 1.87 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.188 -0.945 . . . . 0.0 109.457 -179.859 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.591 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -84.62 -3.13 58.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.922 . . . . 0.0 109.558 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -90.0 42.58 1.1 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 12' ' ' VAL . 3.4 p -114.38 70.31 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.735 -0.603 . . . . 0.0 110.055 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 53.45 61.68 3.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 0.0 109.544 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.512 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 10.3 mt -66.49 175.19 2.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.342 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.81 152.04 36.26 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.38 80.15 2.98 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.642 2.228 . . . . 0.0 110.442 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.34 169.8 54.6 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.89 -65.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.617 2.212 . . . . 0.0 110.382 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.5 m -142.24 139.61 32.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.202 -0.936 . . . . 0.0 109.47 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 117.5 -148.57 18.72 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.267 -1.137 . . . . 0.0 109.409 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.72 -30.56 11.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -0.941 . . . . 0.0 109.658 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.4 8.89 17.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -0.943 . . . . 0.0 109.982 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 tt -67.17 -31.74 72.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.013 -1.055 . . . . 0.0 109.292 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.44 6.31 23.87 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.199 -0.938 . . . . 0.0 109.347 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' A' ' 11' ' ' GLN . 11.3 tp60 -92.07 38.55 1.0 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 12' ' ' VAL . 2.5 p -105.06 83.07 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.823 -0.548 . . . . 0.0 110.063 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 14' ' ' LEU . 3.3 mm-40 51.9 28.72 5.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.239 -0.913 . . . . 0.0 109.686 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.535 ' N ' HD21 ' A' ' 14' ' ' LEU . 0.6 OUTLIER -48.72 176.61 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.07 -1.019 . . . . 0.0 109.478 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.36 153.77 6.58 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.29 79.2 3.36 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.656 2.237 . . . . 0.0 110.465 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -159.84 -88.65 0.07 OUTLIER Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.42 -1.36 11.53 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.594 2.196 . . . . 0.0 110.126 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.74 177.01 7.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.93 . . . . 0.0 109.467 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -142.64 -161.62 8.88 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.274 -1.133 . . . . 0.0 109.585 179.87 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 121.245 0.545 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -93.85 -31.69 14.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.276 -0.89 . . . . 0.0 109.238 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 53.43 32.26 13.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.418 -0.801 . . . . 0.0 109.515 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.84 -70.64 0.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.614 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -79.28 4.66 14.45 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.1 -1.0 . . . . 0.0 109.573 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -88.32 40.29 0.95 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 12' ' ' VAL . 3.4 p -118.81 98.84 6.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.682 -0.636 . . . . 0.0 110.144 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 12' ' ' VAL . 0.3 OUTLIER 42.54 56.54 3.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.094 -1.004 . . . . 0.0 109.715 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 13' ' ' GLU . 4.9 mt -46.36 169.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.575 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -165.11 95.71 0.12 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.76 74.33 5.26 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.526 2.151 . . . . 0.0 110.719 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.14 74.76 1.28 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.37 -75.03 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.581 2.187 . . . . 0.0 110.156 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.02 -16.54 12.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.461 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -147.75 -179.51 23.81 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.312 -1.11 . . . . 0.0 109.601 -180.0 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtt . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.34 0.59 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.17 -69.78 2.07 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.414 ' O ' ' O ' ' A' ' 4' ' ' ALA . 1.0 OUTLIER -77.33 -27.61 52.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -1.156 . . . . 0.0 109.599 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.414 ' O ' ' O ' ' A' ' 3' ' ' LYS . . . 61.09 151.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.133 -0.979 . . . . 0.0 109.356 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -136.44 158.82 43.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -0.893 . . . . 0.0 109.516 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.454 ' HB3' ' HB2' ' A' ' 9' ' ' LEU . 3.6 t-20 -99.27 -176.94 3.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 109.58 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -92.26 -55.43 3.42 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.333 -0.854 . . . . 0.0 109.363 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -127.91 53.14 1.8 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.387 -0.821 . . . . 0.0 109.57 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.506 HD12 ' N ' ' A' ' 10' ' ' TYR . 3.5 tm? -88.97 -71.36 0.6 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 109.442 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.542 ' CD1' ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -76.42 4.18 9.59 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.301 -0.874 . . . . 0.0 110.333 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.06 32.67 0.74 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.49 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 2.3 p -105.95 68.95 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.698 -0.626 . . . . 0.0 109.524 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 49.74 55.77 8.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.329 -0.857 . . . . 0.0 109.429 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.414 HD12 ' HB2' ' A' ' 10' ' ' TYR . 0.8 OUTLIER -56.04 173.23 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 109.414 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 14' ' ' LEU . . . 55.29 100.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.91 78.49 3.55 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.425 2.083 . . . . 0.0 110.291 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.51 80.06 0.34 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.26 -81.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.671 2.247 . . . . 0.0 110.43 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.4 t -57.54 132.51 53.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 109.612 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.95 -147.45 49.46 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.27 -174.9 2.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.305 -1.115 . . . . 0.0 109.517 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.447 ' O ' ' CB ' ' A' ' 23' ' ' ALA . 5.7 ttt -110.99 156.46 21.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.37 -0.831 . . . . 0.0 109.419 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 22' ' ' MET . . . 167.67 67.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 0.0 109.517 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.43 16.47 24.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.901 . . . . 0.0 109.387 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.0 mptt 52.3 68.48 0.81 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.528 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.8 tpt -149.13 -60.14 0.22 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.167 -0.958 . . . . 0.0 109.312 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.4 p -124.91 91.15 3.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.507 -0.745 . . . . 0.0 109.229 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.65 81.02 1.38 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.686 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.22 57.28 1.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.38 -0.825 . . . . 0.0 109.259 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -67.76 0.43 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.604 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 174.93 74.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.324 -0.86 . . . . 0.0 109.483 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.73 -97.55 0.02 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.8 ptt180 -98.49 -170.42 1.95 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -1.15 . . . . 0.0 109.443 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 CA-C-O 118.05 -1.417 . . . . 0.0 109.604 179.979 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.4 ttp . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.39 31.76 2.72 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt 58.6 63.93 1.57 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -1.144 . . . . 0.0 109.467 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -115.25 111.47 20.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.343 -0.848 . . . . 0.0 109.413 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.11 156.31 27.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 109.426 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -133.48 -45.94 0.82 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.334 -0.854 . . . . 0.0 109.342 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -98.48 -25.76 14.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.458 -0.776 . . . . 0.0 109.408 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -91.3 47.23 1.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.14 -0.975 . . . . 0.0 109.576 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.7 tt -82.04 -19.93 39.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.161 -0.962 . . . . 0.0 109.439 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.409 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -80.92 6.6 12.8 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.228 -0.92 . . . . 0.0 109.504 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.42 34.7 0.95 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.455 ' O ' ' CG2' ' A' ' 12' ' ' VAL . 2.2 p -101.54 71.29 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.832 -0.542 . . . . 0.0 109.603 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 14' ' ' LEU . 1.3 tt0 54.75 46.38 24.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.314 -0.866 . . . . 0.0 109.534 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.8 OUTLIER -46.15 171.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 109.336 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.09 137.76 41.09 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.29 78.97 3.43 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.436 2.09 . . . . 0.0 110.521 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.51 178.04 16.63 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.413 ' C ' ' OG ' ' A' ' 19' ' ' SER . 35.9 Cg_endo -78.6 -58.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.662 2.242 . . . . 0.0 110.408 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.413 ' OG ' ' C ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER 62.84 35.46 13.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -0.95 . . . . 0.0 109.369 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.84 -108.82 3.28 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.44 169.98 8.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.228 -1.16 . . . . 0.0 109.461 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.453 ' O ' ' CB ' ' A' ' 23' ' ' ALA . 7.9 mtt -68.25 109.21 3.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.906 . . . . 0.0 109.407 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 22' ' ' MET . . . 168.48 83.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.279 -0.888 . . . . 0.0 109.458 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.09 151.3 19.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.413 ' O ' ' O ' ' A' ' 26' ' ' MET . 1.3 mttp -153.55 84.83 1.18 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.35 -0.844 . . . . 0.0 109.426 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.413 ' O ' ' O ' ' A' ' 25' ' ' LYS . 1.3 ttt 62.79 134.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.494 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.76 112.63 24.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.322 -0.861 . . . . 0.0 109.494 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.58 89.45 1.77 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.235 -0.916 . . . . 0.0 109.49 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp -172.08 -70.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 0.0 109.543 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -138.45 159.92 40.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.164 -0.96 . . . . 0.0 109.461 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 30' ' ' LYS . . . -48.66 176.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.282 -0.886 . . . . 0.0 109.538 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -123.46 -175.19 14.41 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -87.69 147.52 25.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.156 -1.203 . . . . 0.0 109.463 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 CA-C-O 117.94 -1.478 . . . . 0.0 109.568 -179.94 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 ttm . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.307 0.575 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.87 29.7 46.15 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.56 80.73 1.37 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -1.16 . . . . 0.0 109.644 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.53 117.98 28.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -0.929 . . . . 0.0 109.392 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -117.97 -49.71 2.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.137 -0.977 . . . . 0.0 109.571 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -58.66 150.74 22.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 109.527 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.28 -34.77 17.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.347 -0.846 . . . . 0.0 109.144 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.45 ' OE1' ' OE1' ' A' ' 11' ' ' GLN . 2.2 mt-10 -88.63 38.98 0.9 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.415 -0.803 . . . . 0.0 109.534 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.471 ' C ' ' CD1' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -71.18 -58.48 3.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -0.946 . . . . 0.0 109.232 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.518 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -82.88 7.21 15.95 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.221 -0.925 . . . . 0.0 109.387 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.45 ' OE1' ' OE1' ' A' ' 8' ' ' GLU . 4.8 tt0 -89.86 36.94 0.86 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.965 . . . . 0.0 108.415 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 12' ' ' VAL . 2.9 p -110.59 79.99 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.725 -0.609 . . . . 0.0 109.603 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 14' ' ' LEU . 1.1 tt0 50.11 71.23 0.42 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.083 -1.01 . . . . 0.0 108.821 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.498 ' CD2' ' O ' ' A' ' 10' ' ' TYR . 0.9 OUTLIER -42.27 161.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.339 -0.851 . . . . 0.0 109.71 -179.556 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.04 -67.07 0.04 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.15 74.44 5.32 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.657 2.238 . . . . 0.0 110.255 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.75 155.27 20.79 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -80.58 42.87 1.41 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.775 2.317 . . . . 0.0 110.592 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.0 p -59.61 123.2 16.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 109.553 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.3 -141.34 6.24 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -104.46 99.4 9.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -1.144 . . . . 0.0 109.466 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -83.45 -58.57 2.77 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.164 -0.96 . . . . 0.0 109.532 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.452 ' O ' ' CB ' ' A' ' 24' ' ' ALA . . . 67.94 98.41 0.06 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.174 -0.953 . . . . 0.0 109.384 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 23' ' ' ALA . . . 72.91 173.53 0.3 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.196 -0.94 . . . . 0.0 109.47 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 67.17 96.19 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.932 . . . . 0.0 109.427 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 17.4 ttt -139.31 86.94 2.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.183 -0.948 . . . . 0.0 109.566 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 67.7 m -116.65 111.51 19.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.942 . . . . 0.0 109.406 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 27' ' ' SER . 2.5 mmmm 65.32 137.76 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.299 -0.875 . . . . 0.0 109.364 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.72 23.27 14.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.124 -0.985 . . . . 0.0 109.577 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -87.49 164.21 16.27 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.298 -0.876 . . . . 0.0 109.343 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.3 92.15 9.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 109.574 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.5 -170.58 20.43 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -178.9 134.04 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.209 -1.171 . . . . 0.0 109.498 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 CA-C-O 118.017 -1.435 . . . . 0.0 109.651 179.991 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -102.7 69.86 0.32 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -73.77 -23.76 59.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.306 -1.114 . . . . 0.0 109.361 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.77 -173.03 3.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.451 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.25 98.06 11.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.414 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.38 169.17 8.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.225 -0.922 . . . . 0.0 109.539 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.509 ' N ' ' CD1' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -89.5 -63.87 1.22 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.279 -0.888 . . . . 0.0 109.423 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 7' ' ' TYR . 11.8 mt-10 64.12 65.25 0.69 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.435 -0.79 . . . . 0.0 109.391 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 tt -120.19 -47.61 2.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.184 -0.947 . . . . 0.0 109.329 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -84.34 10.82 9.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.276 -0.89 . . . . 0.0 109.268 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.97 32.89 0.88 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 12' ' ' VAL . 3.7 p -109.96 76.63 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 121.383 0.611 . . . . 0.0 109.457 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 51.93 63.6 2.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.119 -0.988 . . . . 0.0 109.284 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 10' ' ' TYR . 5.1 mt -45.64 165.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.351 -0.843 . . . . 0.0 109.659 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.2 -90.8 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.61 -164.87 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.804 2.336 . . . . 0.0 110.45 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.36 -94.96 0.15 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.85 -24.97 8.09 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.53 2.153 . . . . 0.0 110.507 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.01 -168.32 1.88 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.31 -0.869 . . . . 0.0 109.476 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 21' ' ' ASP . . . -68.09 -101.41 0.03 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.502 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 15.8 t70 74.68 87.0 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -1.126 . . . . 0.0 109.545 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.52 -44.51 14.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.172 -0.955 . . . . 0.0 109.334 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -162.94 78.31 0.46 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.34 -0.85 . . . . 0.0 109.31 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.405 ' HB3' ' OD1' ' A' ' 21' ' ' ASP . . . -93.17 98.89 11.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.26 -0.9 . . . . 0.0 109.673 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.42 ' HD3' ' O ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER 56.92 69.46 0.74 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 0.0 109.551 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.416 ' O ' ' HE2' ' A' ' 25' ' ' LYS . 1.8 ttp -48.4 112.55 0.61 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.911 . . . . 0.0 109.436 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.62 142.11 30.9 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.354 -0.841 . . . . 0.0 109.444 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -154.31 128.61 9.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -0.885 . . . . 0.0 109.542 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 64.11 119.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.249 -0.907 . . . . 0.0 109.646 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.1 -37.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.922 . . . . 0.0 109.232 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.28 -34.79 14.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 109.295 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.11 174.74 29.46 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.74 42.04 1.22 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.253 -1.145 . . . . 0.0 109.609 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mtp . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 113.61 120.22 3.59 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.6 mttt 58.58 -177.38 0.08 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.204 -1.174 . . . . 0.0 109.616 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.73 -72.21 0.33 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.274 -0.891 . . . . 0.0 109.233 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -94.53 150.79 19.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 0.0 109.145 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 7' ' ' TYR . 0.9 OUTLIER -154.53 -49.84 0.09 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.096 -1.002 . . . . 0.0 109.774 -179.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.473 ' O ' ' O ' ' A' ' 6' ' ' ASN . 2.6 m-85 -40.81 165.48 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.243 -0.911 . . . . 0.0 110.712 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 7' ' ' TYR . 0.8 OUTLIER -157.04 -101.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.54 -0.725 . . . . 0.0 109.537 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.483 ' O ' HG11 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -127.69 -131.22 0.23 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.956 -1.09 . . . . 0.0 108.827 -179.721 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.56 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -68.01 -1.66 6.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.686 -1.259 . . . . 0.0 110.616 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.417 ' N ' ' HD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -91.49 32.01 1.11 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.792 -1.193 . . . . 0.0 108.166 179.19 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 12' ' ' VAL . 3.1 p -105.72 98.97 7.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 121.299 0.571 . . . . 0.0 109.78 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER 48.54 31.05 2.69 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.164 -0.96 . . . . 0.0 109.405 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.528 ' N ' HD21 ' A' ' 14' ' ' LEU . 0.6 OUTLIER -50.24 179.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.286 -0.884 . . . . 0.0 109.701 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -123.8 -76.45 0.32 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -76.87 80.48 2.82 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.652 2.234 . . . . 0.0 110.627 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -103.81 -149.77 20.76 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.06 -34.11 1.81 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.411 2.074 . . . . 0.0 110.087 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -122.24 165.87 15.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.366 -0.834 . . . . 0.0 109.189 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.43 -97.14 0.89 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -85.39 46.06 1.25 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -1.153 . . . . 0.0 109.893 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.93 144.24 57.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.939 . . . . 0.0 109.125 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -147.17 85.7 1.61 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.099 -1.0 . . . . 0.0 109.738 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -123.45 16.46 9.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.844 . . . . 0.0 109.439 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.455 ' O ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -165.07 76.46 0.28 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.847 . . . . 0.0 109.351 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -151.03 137.67 18.79 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.28 -0.887 . . . . 0.0 109.409 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.31 179.85 6.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.249 -0.907 . . . . 0.0 109.466 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.32 86.21 1.82 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.381 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.5 tptm -157.42 60.11 0.5 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 109.465 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.408 ' O ' ' O ' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -84.63 -22.37 29.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.218 -0.926 . . . . 0.0 109.341 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.408 ' O ' ' O ' ' A' ' 30' ' ' LYS . . . 60.79 153.62 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.465 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.47 90.33 0.08 OUTLIER Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 47.99 24.49 0.63 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -1.131 . . . . 0.0 109.487 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.939 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.31 0.576 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.95 143.47 4.85 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -139.46 160.13 40.55 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.305 -1.114 . . . . 0.0 109.591 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -173.11 61.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.117 -0.989 . . . . 0.0 109.497 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -148.74 63.73 1.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.314 -0.866 . . . . 0.0 109.498 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -146.32 112.06 5.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -0.892 . . . . 0.0 109.525 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -96.03 -78.79 0.45 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.39 -0.819 . . . . 0.0 109.31 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 7' ' ' TYR . 18.2 mt-10 42.12 44.55 3.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 109.705 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' A' ' 10' ' ' TYR . 10.2 tt -67.33 -86.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.416 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.551 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -74.88 3.72 7.7 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.912 -1.117 . . . . 0.0 110.531 -179.77 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.4 ' N ' ' HD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -93.58 32.63 1.36 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.019 -1.051 . . . . 0.0 108.187 179.139 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 12' ' ' VAL . 2.4 p -101.98 87.19 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.66 -0.65 . . . . 0.0 110.008 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 12' ' ' VAL . 16.4 mm-40 44.54 48.45 8.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.135 -0.978 . . . . 0.0 109.349 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 10' ' ' TYR . 1.7 mt -47.48 151.4 0.79 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.386 -0.821 . . . . 0.0 109.514 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -109.56 156.83 15.42 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.9 82.46 2.42 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.641 2.227 . . . . 0.0 110.491 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.91 167.12 22.4 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.49 -41.21 0.27 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.606 2.204 . . . . 0.0 110.452 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.7 t -84.21 149.55 26.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -0.85 . . . . 0.0 109.478 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 21' ' ' ASP . . . -164.06 -162.83 15.7 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.44 ' O ' ' O ' ' A' ' 20' ' ' GLY . 8.3 m-20 60.95 122.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -1.145 . . . . 0.0 109.45 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 5.9 mtp -95.62 83.44 3.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.49 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -121.41 62.48 0.91 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.375 -0.828 . . . . 0.0 109.41 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -171.68 -38.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 109.606 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -129.48 63.92 1.5 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 109.62 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.4 ttt -102.15 172.9 6.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.206 -0.934 . . . . 0.0 109.354 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.17 179.81 6.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.256 -0.903 . . . . 0.0 109.729 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.74 100.22 13.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.31 -0.869 . . . . 0.0 109.532 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 16.2 pttm -128.44 126.79 41.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.186 -0.946 . . . . 0.0 109.374 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 32' ' ' GLY . 32.1 mmtp -105.82 -165.55 1.12 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.319 -0.863 . . . . 0.0 109.448 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.54 91.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.527 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 30' ' ' LYS . . . -132.26 160.46 23.68 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.34 109.17 6.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.223 -1.163 . . . . 0.0 109.476 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 CA-C-O 118.01 -1.439 . . . . 0.0 109.556 -179.847 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.252 0.549 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.62 -154.38 30.59 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -80.24 104.96 11.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -1.208 . . . . 0.0 109.441 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -157.69 152.55 25.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -0.891 . . . . 0.0 109.345 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.71 -65.49 0.98 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.158 -0.964 . . . . 0.0 109.603 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.522 ' O ' ' CB ' ' A' ' 11' ' ' GLN . 1.2 m120 -73.47 111.03 8.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 109.807 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.59 -30.46 16.36 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.178 -0.951 . . . . 0.0 109.137 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -113.3 15.63 19.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.326 -0.859 . . . . 0.0 109.879 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.521 ' CB ' ' HB3' ' A' ' 6' ' ' ASN . 0.2 OUTLIER -104.84 -142.24 0.37 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.021 -1.049 . . . . 0.0 109.266 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.51 ' CE1' HD21 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -65.0 -6.19 8.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.111 -0.993 . . . . 0.0 110.47 -179.553 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.522 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 1.0 OUTLIER -90.4 40.39 1.01 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.957 -1.089 . . . . 0.0 108.126 179.254 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 12' ' ' VAL . 2.8 p -113.31 85.62 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.783 -0.573 . . . . 0.0 109.754 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER 45.44 75.77 0.1 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.005 -1.059 . . . . 0.0 108.951 -179.607 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 13' ' ' GLU . 3.4 mm? -44.2 169.07 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.362 -0.836 . . . . 0.0 109.689 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.01 176.6 23.97 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.48 86.66 1.64 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.612 2.208 . . . . 0.0 110.532 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 61.15 86.69 0.04 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.19 -70.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.617 2.211 . . . . 0.0 110.512 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.433 ' O ' ' OG ' ' A' ' 19' ' ' SER . 26.3 p -175.37 93.91 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.136 -0.978 . . . . 0.0 109.659 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 142.64 -132.92 5.32 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.2 p30 -83.83 178.05 8.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.203 -1.175 . . . . 0.0 109.528 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 6.6 ttm -143.05 -163.37 1.62 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 109.518 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 46.3 71.98 0.26 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 109.5 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -122.91 65.07 0.97 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.397 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.36 80.38 1.35 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.47 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.52 116.04 4.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.301 -0.875 . . . . 0.0 109.304 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.83 125.68 2.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.183 -0.948 . . . . 0.0 109.743 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -119.05 140.47 49.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.268 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -145.57 -49.93 0.24 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.093 -1.004 . . . . 0.0 109.717 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.428 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -172.48 74.82 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 109.559 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 30' ' ' LYS . . . 168.85 70.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.46 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.62 111.62 4.32 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -102.3 135.76 43.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -1.143 . . . . 0.0 109.463 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 CA-C-O 117.903 -1.498 . . . . 0.0 109.526 179.999 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.293 0.568 . . . . 0.0 109.571 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 154.05 -140.87 7.8 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -150.88 152.36 33.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -1.121 . . . . 0.0 109.368 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.55 112.34 5.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.331 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -75.68 82.3 2.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.547 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -113.15 -43.77 3.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.359 -0.838 . . . . 0.0 109.485 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.91 -66.74 0.85 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 109.23 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 45.89 72.52 0.22 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.485 -0.76 . . . . 0.0 109.453 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.47 -139.37 0.27 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.889 . . . . 0.0 109.147 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.529 ' CD1' ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -68.63 -2.67 9.6 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.942 -1.099 . . . . 0.0 110.499 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.478 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.9 OUTLIER -90.28 34.05 0.88 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.229 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.476 HG13 ' O ' ' A' ' 12' ' ' VAL . 3.4 p -103.77 78.02 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.355 0.597 . . . . 0.0 109.496 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER 56.41 64.99 1.53 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.074 -1.016 . . . . 0.0 108.816 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -48.52 -179.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.411 -0.805 . . . . 0.0 109.862 -179.542 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -169.48 94.68 0.11 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.03 86.79 1.64 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.638 2.225 . . . . 0.0 110.944 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.9 77.92 1.38 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.59 -63.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.692 2.261 . . . . 0.0 110.549 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.27 116.14 12.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 109.903 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.34 179.37 2.99 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -129.33 54.69 1.8 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -1.142 . . . . 0.0 109.376 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -126.0 57.91 1.36 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 109.497 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 172.19 84.9 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.297 -0.877 . . . . 0.0 109.573 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.28 -59.03 4.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.196 -0.94 . . . . 0.0 109.265 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 50.71 79.01 0.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.655 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.418 ' O ' ' CB ' ' A' ' 27' ' ' SER . 7.1 mtt -133.79 168.95 17.8 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.327 -0.858 . . . . 0.0 109.401 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.5 OUTLIER 68.74 -178.63 0.22 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.889 . . . . 0.0 109.361 -179.858 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 27' ' ' SER . 0.3 OUTLIER 69.18 163.83 0.24 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 109.479 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.93 166.29 22.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 0.0 109.519 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.51 67.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.9 . . . . 0.0 109.556 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.67 124.22 15.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.068 -1.02 . . . . 0.0 109.455 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.82 75.37 0.27 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -62.89 -58.95 5.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -1.148 . . . . 0.0 109.534 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 CA-C-O 117.933 -1.482 . . . . 0.0 109.554 179.945 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mtm . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.7 -179.74 29.83 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -102.66 70.74 1.14 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.357 -1.084 . . . . 0.0 109.422 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . -116.79 42.21 2.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.344 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 4' ' ' ALA . 1.7 mt-10 65.11 144.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.473 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -92.48 151.1 20.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 109.441 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.591 ' N ' ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -93.04 -30.73 15.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 0.0 109.369 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 67.19 59.44 0.53 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.48 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 tt -71.28 -7.25 45.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.635 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -88.31 -5.08 58.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.18 -0.95 . . . . 0.0 109.399 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.66 41.06 1.02 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 12' ' ' VAL . 2.7 p -112.93 93.89 2.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.708 -0.62 . . . . 0.0 109.925 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 12' ' ' VAL . 8.6 tp10 44.47 51.38 7.87 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.11 -0.994 . . . . 0.0 109.248 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 10' ' ' TYR . 1.4 mt -55.7 -179.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.353 -0.842 . . . . 0.0 109.631 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.71 -64.42 0.17 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.27 81.38 2.64 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.646 2.231 . . . . 0.0 110.285 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.71 -173.6 7.05 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.32 -63.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.663 2.242 . . . . 0.0 110.495 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 71.2 p -125.36 24.35 7.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.262 -0.899 . . . . 0.0 109.572 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.56 -148.82 14.49 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.52 -64.94 0.66 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -1.146 . . . . 0.0 109.423 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 15.7 mtt -81.67 150.42 28.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 109.542 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 173.55 69.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.229 -0.92 . . . . 0.0 109.472 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 64.71 109.74 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.881 . . . . 0.0 109.521 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -170.01 60.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -0.951 . . . . 0.0 109.512 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.8 tpp -152.44 123.06 7.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 0.0 109.304 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.3 t -144.41 143.64 31.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.195 -0.941 . . . . 0.0 109.729 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -137.19 119.12 15.27 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.279 -0.888 . . . . 0.0 109.231 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 30' ' ' LYS . 0.5 OUTLIER -61.85 -175.73 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.523 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -44.43 120.86 2.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.669 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -126.73 118.42 24.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.882 . . . . 0.0 109.403 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.51 -118.7 0.02 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -42.47 78.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -1.139 . . . . 0.0 109.396 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 CA-C-O 117.967 -1.463 . . . . 0.0 109.596 -179.957 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.5 ptm . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.06 -140.83 21.1 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 4' ' ' ALA . 1.5 pttt -158.83 68.84 0.46 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -1.185 . . . . 0.0 109.593 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 3' ' ' LYS . . . 69.14 -177.43 0.21 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 109.713 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 178.51 -156.42 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.264 -0.897 . . . . 0.0 109.317 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -149.7 -174.58 4.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 0.0 109.402 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.25 -67.64 0.77 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.139 -0.976 . . . . 0.0 109.431 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.438 ' OE2' HG21 ' A' ' 12' ' ' VAL . 1.8 mt-10 52.4 74.87 0.25 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.397 -0.815 . . . . 0.0 109.207 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.541 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -90.97 -145.52 0.19 Allowed 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.135 -0.978 . . . . 0.0 109.364 -179.742 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.541 ' N ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -70.59 -1.98 12.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.137 -0.977 . . . . 0.0 110.342 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.408 ' N ' ' HD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -94.14 31.6 1.65 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.132 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.491 HG11 ' O ' ' A' ' 9' ' ' LEU . 2.6 p -96.97 75.91 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 14' ' ' LEU . 1.0 OUTLIER 47.19 53.04 11.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.17 -0.956 . . . . 0.0 109.213 -179.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.542 ' N ' HD21 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -48.26 178.13 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.392 -0.817 . . . . 0.0 110.004 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.2 -78.85 0.09 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -80.8 -165.33 0.33 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.731 2.287 . . . . 0.0 110.746 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -166.31 -156.28 9.4 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.66 -9.69 15.86 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.62 2.213 . . . . 0.0 110.48 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.49 -92.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 109.581 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 21' ' ' ASP . . . -104.78 -159.2 23.65 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 1.6 m-20 69.46 128.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -1.131 . . . . 0.0 109.512 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.447 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 24.5 ttp -105.24 -44.32 4.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.18 -0.95 . . . . 0.0 109.47 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 22' ' ' MET . . . 61.54 60.3 1.69 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -0.849 . . . . 0.0 109.455 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -109.8 119.35 39.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.201 -0.937 . . . . 0.0 109.52 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 7.1 mmtp 66.05 72.8 0.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.292 -0.88 . . . . 0.0 109.524 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -159.44 127.27 4.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.303 -0.873 . . . . 0.0 109.277 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.5 m -130.1 176.65 7.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -0.982 . . . . 0.0 109.848 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 29' ' ' LYS . 4.3 mttt -149.44 175.59 11.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.359 -0.838 . . . . 0.0 109.131 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 28' ' ' LYS . 1.8 mtpt 61.32 125.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.141 -0.975 . . . . 0.0 109.527 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.29 38.35 0.86 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.893 . . . . 0.0 109.404 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.77 20.97 16.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 109.467 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -157.58 -49.4 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.99 19.83 19.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.163 -1.198 . . . . 0.0 109.561 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 CA-C-O 117.914 -1.492 . . . . 0.0 109.483 -179.979 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 ttt . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.6 136.19 0.31 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.29 43.33 10.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -1.122 . . . . 0.0 109.441 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -114.54 39.05 2.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.156 -0.965 . . . . 0.0 109.418 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -124.06 139.12 54.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.266 -0.896 . . . . 0.0 109.447 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -121.25 162.6 19.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 109.57 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.1 -47.99 9.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.015 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.433 ' HA ' ' OE1' ' A' ' 8' ' ' GLU . 4.2 mm-40 -106.42 65.43 0.68 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.469 -0.769 . . . . 0.0 109.276 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 tt -86.04 8.98 18.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 109.493 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.548 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -87.41 -8.01 57.05 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.317 -0.864 . . . . 0.0 109.63 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.12 40.06 0.99 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 12' ' ' VAL . 2.2 p -106.63 75.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.392 0.615 . . . . 0.0 109.96 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 12' ' ' VAL . 60.7 mt-10 43.9 44.0 5.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.289 -0.882 . . . . 0.0 109.591 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.519 ' CD2' ' N ' ' A' ' 15' ' ' GLY . 5.2 tt -47.8 153.07 0.65 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.27 -0.894 . . . . 0.0 109.427 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.519 ' N ' ' CD2' ' A' ' 14' ' ' LEU . . . 165.6 168.32 27.59 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.3 81.27 2.78 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.758 2.305 . . . . 0.0 110.415 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.32 174.58 3.61 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.74 -3.16 13.28 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.549 2.166 . . . . 0.0 110.321 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.7 m -135.75 163.63 29.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.241 -0.912 . . . . 0.0 109.409 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.79 -151.99 23.65 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -94.44 163.28 13.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.274 -1.133 . . . . 0.0 109.351 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 3.2 ttt -137.27 36.01 2.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.306 -0.871 . . . . 0.0 109.502 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.45 60.29 1.7 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.268 -0.895 . . . . 0.0 109.409 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 25' ' ' LYS . . . -140.14 -41.75 0.43 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.35 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 26' ' ' MET . 1.8 ttpm? 44.74 75.29 0.11 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.874 . . . . 0.0 109.699 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.447 ' O ' ' O ' ' A' ' 25' ' ' LYS . 0.3 OUTLIER 57.32 111.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 0.0 109.654 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.9 p -115.67 90.24 3.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.351 -0.843 . . . . 0.0 109.223 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.3 tttt -74.06 135.87 43.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.897 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp 45.43 81.35 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.302 -0.874 . . . . 0.0 109.842 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -75.29 113.3 12.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -0.929 . . . . 0.0 109.109 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.32 161.39 28.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.102 -0.999 . . . . 0.0 109.732 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 159.2 -161.24 31.9 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -127.99 86.74 2.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -1.193 . . . . 0.0 109.385 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 CA-C-O 117.974 -1.459 . . . . 0.0 109.535 179.974 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.483 ' O ' ' CB ' ' A' ' 3' ' ' LYS . . . 114.43 84.49 1.24 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER 73.25 43.29 0.39 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -1.146 . . . . 0.0 109.604 179.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.14 109.18 14.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.58 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -160.76 50.12 0.26 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.529 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -94.62 -177.12 4.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.26 -0.9 . . . . 0.0 109.356 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.11 -51.21 4.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.12 -0.987 . . . . 0.0 109.852 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -94.54 25.68 3.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.289 -0.882 . . . . 0.0 109.998 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 tt -72.86 -48.99 32.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.072 -1.017 . . . . 0.0 109.351 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.531 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.5 OUTLIER -75.99 -5.52 46.69 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.279 -0.888 . . . . 0.0 109.757 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -88.32 43.96 1.17 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 12' ' ' VAL . 3.5 p -116.96 78.85 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 121.376 0.608 . . . . 0.0 109.633 -178.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 50.37 74.66 0.21 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.106 -0.996 . . . . 0.0 109.14 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 10' ' ' TYR . 3.9 mm? -49.78 140.67 11.24 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.294 -0.879 . . . . 0.0 109.395 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.04 -94.64 0.49 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.54 75.27 5.04 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.651 2.234 . . . . 0.0 110.51 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.72 -157.32 32.61 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.4 -19.16 11.91 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.61 2.206 . . . . 0.0 110.419 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.9 p -102.24 80.18 1.94 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.286 -0.884 . . . . 0.0 109.457 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -156.56 -64.65 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 38.3 p-10 -64.41 98.8 0.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -1.091 . . . . 0.0 109.54 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.412 ' HE2' ' HA ' ' A' ' 22' ' ' MET . 0.6 OUTLIER -62.99 162.99 10.46 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.215 -0.928 . . . . 0.0 109.419 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 177.87 97.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 0.0 109.461 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.27 86.59 5.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.325 -0.859 . . . . 0.0 109.679 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt 54.17 76.18 0.25 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -0.886 . . . . 0.0 109.538 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 21.0 mtp -108.85 -168.59 1.36 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.41 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.9 m 49.31 74.98 0.17 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.327 -0.858 . . . . 0.0 109.512 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 ttpt -107.77 83.34 1.78 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.276 -0.89 . . . . 0.0 109.287 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.04 -95.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.488 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -153.15 -64.37 0.15 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.062 -1.024 . . . . 0.0 109.519 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.19 -73.1 0.5 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 0.0 109.649 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.89 49.43 3.12 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.64 88.83 3.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -1.126 . . . . 0.0 109.575 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.993 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ptt? . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.366 0.603 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -124.95 -177.87 15.08 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.68 140.69 28.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -1.15 . . . . 0.0 109.524 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -169.44 160.81 9.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.361 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -94.13 -21.18 19.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 109.509 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.408 ' OD1' ' HG2' ' A' ' 8' ' ' GLU . 21.6 t-20 -73.16 130.78 41.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 109.33 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.405 ' O ' ' C ' ' A' ' 8' ' ' GLU . 0.1 OUTLIER -77.73 -46.03 22.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.151 -0.968 . . . . 0.0 108.786 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.408 ' HG2' ' OD1' ' A' ' 6' ' ' ASN . 0.2 OUTLIER 45.28 36.17 2.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.404 -0.81 . . . . 0.0 109.361 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.457 ' HB3' ' CD1' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -103.97 -58.52 1.87 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.188 -0.945 . . . . 0.0 109.457 -179.859 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.591 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -84.62 -3.13 58.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.922 . . . . 0.0 109.558 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -90.0 42.58 1.1 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 12' ' ' VAL . 3.4 p -114.38 70.31 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.735 -0.603 . . . . 0.0 110.055 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 53.45 61.68 3.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 0.0 109.544 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.512 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 10.3 mt -66.49 175.19 2.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.342 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.81 152.04 36.26 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.38 80.15 2.98 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.642 2.228 . . . . 0.0 110.442 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.34 169.8 54.6 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.89 -65.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.617 2.212 . . . . 0.0 110.382 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.5 m -142.24 139.61 32.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.202 -0.936 . . . . 0.0 109.47 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 117.5 -148.57 18.72 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.498 ' O ' ' CG ' ' A' ' 22' ' ' MET . 0.9 OUTLIER 60.86 31.51 20.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -1.137 . . . . 0.0 109.409 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.498 ' CG ' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER 171.94 158.69 0.1 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 109.263 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 53.93 82.49 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.185 -0.947 . . . . 0.0 109.396 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.72 -158.79 0.21 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -0.893 . . . . 0.0 109.709 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.71 58.84 5.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.284 -0.885 . . . . 0.0 109.464 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -179.41 -170.35 0.17 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.889 . . . . 0.0 109.42 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 65.93 128.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.195 -0.94 . . . . 0.0 109.387 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 67.0 59.17 0.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.315 -0.866 . . . . 0.0 109.568 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.13 153.78 43.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 109.339 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.58 154.74 31.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.155 -0.966 . . . . 0.0 109.394 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.49 110.91 10.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.314 -0.866 . . . . 0.0 109.479 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.76 -152.04 11.95 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.57 -71.31 0.37 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.227 -1.161 . . . . 0.0 109.417 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 CA-C-O 117.985 -1.453 . . . . 0.0 109.469 -179.952 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.313 0.577 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.28 46.61 1.15 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 4' ' ' ALA . 1.1 mttm -121.93 45.15 2.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -1.163 . . . . 0.0 109.302 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 3' ' ' LYS . . . 44.51 87.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.278 -0.889 . . . . 0.0 109.397 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -158.33 145.31 17.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.244 -0.91 . . . . 0.0 109.536 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -143.77 154.98 44.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.388 -0.82 . . . . 0.0 109.371 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.72 -30.56 11.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -0.941 . . . . 0.0 109.658 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.4 8.89 17.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -0.943 . . . . 0.0 109.982 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 tt -67.17 -31.74 72.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.013 -1.055 . . . . 0.0 109.292 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.44 6.31 23.87 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.199 -0.938 . . . . 0.0 109.347 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' A' ' 11' ' ' GLN . 11.3 tp60 -92.07 38.55 1.0 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 12' ' ' VAL . 2.5 p -105.06 83.07 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.823 -0.548 . . . . 0.0 110.063 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 14' ' ' LEU . 3.3 mm-40 51.9 28.72 5.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.239 -0.913 . . . . 0.0 109.686 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.535 ' N ' HD21 ' A' ' 14' ' ' LEU . 0.6 OUTLIER -48.72 176.61 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.07 -1.019 . . . . 0.0 109.478 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.36 153.77 6.58 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.29 79.2 3.36 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.656 2.237 . . . . 0.0 110.465 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -159.84 -88.65 0.07 OUTLIER Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.42 -1.36 11.53 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.594 2.196 . . . . 0.0 110.126 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.74 177.01 7.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.93 . . . . 0.0 109.467 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -142.64 -161.62 8.88 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -147.24 -46.16 0.17 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -1.133 . . . . 0.0 109.585 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.83 98.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.337 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -170.06 89.25 0.16 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.191 -0.943 . . . . 0.0 109.655 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 58.6 105.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.626 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -157.08 77.41 0.87 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.295 -0.878 . . . . 0.0 109.348 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -179.79 77.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.314 -0.866 . . . . 0.0 109.309 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 28' ' ' LYS . 2.2 m -138.71 59.96 1.61 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.939 . . . . 0.0 109.503 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.453 ' O ' ' O ' ' A' ' 27' ' ' SER . 9.5 tttt 52.94 173.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.272 -0.893 . . . . 0.0 109.608 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -102.65 -14.31 16.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 109.555 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.4 ttmt 56.7 107.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.259 -0.901 . . . . 0.0 109.445 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . 61.15 137.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.266 -0.896 . . . . 0.0 109.479 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.12 37.66 3.26 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.07 27.25 2.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.281 -1.129 . . . . 0.0 109.471 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 CA-C-O 118.014 -1.437 . . . . 0.0 109.602 -179.972 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 148.19 104.6 0.35 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.5 pttt -145.21 141.37 28.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.211 -1.17 . . . . 0.0 109.415 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.52 72.77 1.49 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.448 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.54 140.35 26.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -70.8 146.6 49.64 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.278 -0.889 . . . . 0.0 109.683 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -93.85 -31.69 14.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.276 -0.89 . . . . 0.0 109.238 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 53.43 32.26 13.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.418 -0.801 . . . . 0.0 109.515 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.84 -70.64 0.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.614 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -79.28 4.66 14.45 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.1 -1.0 . . . . 0.0 109.573 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -88.32 40.29 0.95 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 12' ' ' VAL . 3.4 p -118.81 98.84 6.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.682 -0.636 . . . . 0.0 110.144 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 12' ' ' VAL . 0.3 OUTLIER 42.54 56.54 3.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.094 -1.004 . . . . 0.0 109.715 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 13' ' ' GLU . 4.9 mt -46.36 169.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.575 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -165.11 95.71 0.12 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.76 74.33 5.26 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.526 2.151 . . . . 0.0 110.719 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.14 74.76 1.28 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.37 -75.03 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.581 2.187 . . . . 0.0 110.156 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.02 -16.54 12.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.461 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -147.75 -179.51 23.81 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 61.98 150.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -1.11 . . . . 0.0 109.601 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.17 -67.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.572 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -171.93 72.53 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 109.477 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 25' ' ' LYS . . . -129.12 113.85 15.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.576 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 1.8 tmmt? 65.63 82.5 0.18 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.194 -0.941 . . . . 0.0 109.551 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.458 ' O ' ' HB3' ' A' ' 27' ' ' SER . 1.7 ttp -152.72 -44.3 0.1 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.199 -0.938 . . . . 0.0 109.392 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' ' 26' ' ' MET . 68.7 p 174.95 165.43 0.27 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.409 -0.807 . . . . 0.0 109.302 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.39 115.82 13.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.227 -0.92 . . . . 0.0 109.689 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.448 ' HE3' ' HB1' ' A' ' 31' ' ' ALA . 53.0 pttt -141.33 164.77 29.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -0.829 . . . . 0.0 109.382 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt -107.62 59.36 0.62 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.172 -0.955 . . . . 0.0 109.521 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.448 ' HB1' ' HE3' ' A' ' 29' ' ' LYS . . . -85.29 153.09 22.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.218 -0.926 . . . . 0.0 109.404 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.66 151.97 28.4 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.58 154.24 17.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -1.124 . . . . 0.0 109.442 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 CA-C-O 118.049 -1.417 . . . . 0.0 109.563 -179.928 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.494 ' HB3' ' HB2' ' A' ' 9' ' ' LEU . 3.6 t-20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.266 0.555 . . . . 0.0 109.58 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -92.26 -55.43 3.42 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.333 -0.854 . . . . 0.0 109.363 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -127.91 53.14 1.8 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.387 -0.821 . . . . 0.0 109.57 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.749 ' C ' HD13 ' A' ' 9' ' ' LEU . 3.5 tm? -88.97 -71.36 0.6 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 109.442 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.542 ' CD1' ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -76.42 4.18 9.59 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.301 -0.874 . . . . 0.0 110.333 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.06 32.67 0.74 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.746 ' O ' HG22 ' A' ' 12' ' ' VAL . 2.3 p -105.95 68.95 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.698 -0.626 . . . . 0.0 109.524 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 49.74 55.77 8.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.329 -0.857 . . . . 0.0 109.429 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' A' ' 15' ' ' GLY . 0.8 OUTLIER -56.04 173.23 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 109.414 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 14' ' ' LEU . . . 55.29 100.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.91 78.49 3.55 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.425 2.083 . . . . 0.0 110.291 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.51 80.06 0.34 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.26 -81.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.671 2.247 . . . . 0.0 110.43 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.4 t -57.54 132.51 53.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 109.612 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.95 -147.45 49.46 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.305 -1.115 . . . . 0.0 109.517 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -98.48 -25.76 14.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.458 -0.776 . . . . 0.0 109.408 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -91.3 47.23 1.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.14 -0.975 . . . . 0.0 109.576 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.7 tt -82.04 -19.93 39.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.161 -0.962 . . . . 0.0 109.439 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.409 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -80.92 6.6 12.8 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.228 -0.92 . . . . 0.0 109.504 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.42 34.7 0.95 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.74 ' O ' HG22 ' A' ' 12' ' ' VAL . 2.2 p -101.54 71.29 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.832 -0.542 . . . . 0.0 109.603 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 14' ' ' LEU . 1.3 tt0 54.75 46.38 24.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.314 -0.866 . . . . 0.0 109.534 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.8 OUTLIER -46.15 171.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 109.336 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.09 137.76 41.09 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.29 78.97 3.43 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.436 2.09 . . . . 0.0 110.521 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.51 178.04 16.63 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.413 ' C ' ' OG ' ' A' ' 19' ' ' SER . 35.9 Cg_endo -78.6 -58.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.662 2.242 . . . . 0.0 110.408 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.413 ' OG ' ' C ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER 62.84 35.46 13.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -0.95 . . . . 0.0 109.369 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.84 -108.82 3.28 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.228 -1.16 . . . . 0.0 109.461 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.8 m120 . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.28 -34.77 17.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.347 -0.846 . . . . 0.0 109.144 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.45 ' OE1' ' OE1' ' A' ' 11' ' ' GLN . 2.2 mt-10 -88.63 38.98 0.9 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.415 -0.803 . . . . 0.0 109.534 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.576 HD13 ' O ' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -71.18 -58.48 3.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -0.946 . . . . 0.0 109.232 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.518 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -82.88 7.21 15.95 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.221 -0.925 . . . . 0.0 109.387 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.45 ' OE1' ' OE1' ' A' ' 8' ' ' GLU . 4.8 tt0 -89.86 36.94 0.86 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.965 . . . . 0.0 108.415 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.508 ' O ' HG22 ' A' ' 12' ' ' VAL . 2.9 p -110.59 79.99 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.725 -0.609 . . . . 0.0 109.603 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 14' ' ' LEU . 1.1 tt0 50.11 71.23 0.42 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.083 -1.01 . . . . 0.0 108.821 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.519 ' HA ' HD13 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -42.27 161.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.339 -0.851 . . . . 0.0 109.71 -179.556 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.04 -67.07 0.04 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.15 74.44 5.32 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.657 2.238 . . . . 0.0 110.255 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.75 155.27 20.79 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -80.58 42.87 1.41 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.775 2.317 . . . . 0.0 110.592 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.0 p -59.61 123.2 16.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 109.553 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.3 -141.34 6.24 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.255 -1.144 . . . . 0.0 109.466 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.387 0.613 . . . . 0.0 109.539 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.509 ' N ' ' CD1' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -89.5 -63.87 1.22 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.279 -0.888 . . . . 0.0 109.423 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 7' ' ' TYR . 11.8 mt-10 64.12 65.25 0.69 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.435 -0.79 . . . . 0.0 109.391 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.492 HD23 ' O ' ' A' ' 9' ' ' LEU . 4.6 tt -120.19 -47.61 2.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.184 -0.947 . . . . 0.0 109.329 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.449 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -84.34 10.82 9.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.276 -0.89 . . . . 0.0 109.268 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.97 32.89 0.88 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 12' ' ' VAL . 3.7 p -109.96 76.63 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 121.383 0.611 . . . . 0.0 109.457 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 51.93 63.6 2.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.119 -0.988 . . . . 0.0 109.284 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 14' ' ' LEU . 5.1 mt -45.64 165.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.351 -0.843 . . . . 0.0 109.659 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.2 -90.8 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.61 -164.87 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.804 2.336 . . . . 0.0 110.45 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.407 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 151.36 -94.96 0.15 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.407 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 35.4 Cg_endo -77.85 -24.97 8.09 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.53 2.153 . . . . 0.0 110.507 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.01 -168.32 1.88 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.31 -0.869 . . . . 0.0 109.476 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 21' ' ' ASP . . . -68.09 -101.41 0.03 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.502 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 15.8 t70 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.286 -1.126 . . . . 0.0 109.545 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 7' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.169 0.509 . . . . 0.0 109.774 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.506 ' CE2' HG21 ' A' ' 12' ' ' VAL . 2.6 m-85 -40.81 165.48 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.243 -0.911 . . . . 0.0 110.712 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 7' ' ' TYR . 0.8 OUTLIER -157.04 -101.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.54 -0.725 . . . . 0.0 109.537 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.589 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -127.69 -131.22 0.23 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.956 -1.09 . . . . 0.0 108.827 -179.721 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.589 ' N ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -68.01 -1.66 6.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.686 -1.259 . . . . 0.0 110.616 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.419 ' N ' ' HD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -91.49 32.01 1.11 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.792 -1.193 . . . . 0.0 108.166 179.19 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 9' ' ' LEU . 3.1 p -105.72 98.97 7.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 121.299 0.571 . . . . 0.0 109.78 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER 48.54 31.05 2.69 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.164 -0.96 . . . . 0.0 109.405 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -50.24 179.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.286 -0.884 . . . . 0.0 109.701 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -123.8 -76.45 0.32 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -76.87 80.48 2.82 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.652 2.234 . . . . 0.0 110.627 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -103.81 -149.77 20.76 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.06 -34.11 1.81 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.411 2.074 . . . . 0.0 110.087 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -122.24 165.87 15.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.366 -0.834 . . . . 0.0 109.189 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.43 -97.14 0.89 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.24 -1.153 . . . . 0.0 109.893 -179.672 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.0 t30 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -96.03 -78.79 0.45 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.39 -0.819 . . . . 0.0 109.31 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 7' ' ' TYR . 18.2 mt-10 42.12 44.55 3.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 109.705 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.787 HD23 ' N ' ' A' ' 10' ' ' TYR . 10.2 tt -67.33 -86.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.416 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.787 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -74.88 3.72 7.7 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.912 -1.117 . . . . 0.0 110.531 -179.77 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.406 ' N ' ' HD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -93.58 32.63 1.36 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.019 -1.051 . . . . 0.0 108.187 179.139 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.504 ' O ' HG22 ' A' ' 12' ' ' VAL . 2.4 p -101.98 87.19 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.66 -0.65 . . . . 0.0 110.008 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 12' ' ' VAL . 16.4 mm-40 44.54 48.45 8.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.135 -0.978 . . . . 0.0 109.349 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 10' ' ' TYR . 1.7 mt -47.48 151.4 0.79 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.386 -0.821 . . . . 0.0 109.514 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -109.56 156.83 15.42 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.9 82.46 2.42 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.641 2.227 . . . . 0.0 110.491 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.91 167.12 22.4 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.49 -41.21 0.27 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.606 2.204 . . . . 0.0 110.452 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.7 t -84.21 149.55 26.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -0.85 . . . . 0.0 109.478 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 21' ' ' ASP . . . -164.06 -162.83 15.7 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.44 ' O ' ' O ' ' A' ' 20' ' ' GLY . 8.3 m-20 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.254 -1.145 . . . . 0.0 109.45 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.522 ' O ' ' CB ' ' A' ' 11' ' ' GLN . 9.7 m-20 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.299 0.571 . . . . 0.0 109.807 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.59 -30.46 16.36 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.178 -0.951 . . . . 0.0 109.137 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -113.3 15.63 19.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.326 -0.859 . . . . 0.0 109.879 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.664 HD23 ' H ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -104.84 -142.24 0.37 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.021 -1.049 . . . . 0.0 109.266 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.664 ' H ' HD23 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -65.0 -6.19 8.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.111 -0.993 . . . . 0.0 110.47 -179.553 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.522 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 1.0 OUTLIER -90.4 40.39 1.01 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.957 -1.089 . . . . 0.0 108.126 179.254 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.8 p -113.31 85.62 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.783 -0.573 . . . . 0.0 109.754 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER 45.44 75.77 0.1 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.005 -1.059 . . . . 0.0 108.951 -179.607 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 13' ' ' GLU . 3.4 mm? -44.2 169.07 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.362 -0.836 . . . . 0.0 109.689 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.01 176.6 23.97 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.48 86.66 1.64 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.612 2.208 . . . . 0.0 110.532 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 61.15 86.69 0.04 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.19 -70.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.617 2.211 . . . . 0.0 110.512 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.3 p -175.37 93.91 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.136 -0.978 . . . . 0.0 109.659 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 142.64 -132.92 5.32 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.2 p30 . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.203 -1.175 . . . . 0.0 109.528 -179.964 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.329 0.585 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.91 -66.74 0.85 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 109.23 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 45.89 72.52 0.22 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.485 -0.76 . . . . 0.0 109.453 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.535 HD23 ' H ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -96.47 -139.37 0.27 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.889 . . . . 0.0 109.147 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.535 ' H ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -68.63 -2.67 9.6 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.942 -1.099 . . . . 0.0 110.499 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.478 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.9 OUTLIER -90.28 34.05 0.88 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.229 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.492 ' O ' HG22 ' A' ' 12' ' ' VAL . 3.4 p -103.77 78.02 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.355 0.597 . . . . 0.0 109.496 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER 56.41 64.99 1.53 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.074 -1.016 . . . . 0.0 108.816 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -48.52 -179.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.411 -0.805 . . . . 0.0 109.862 -179.542 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -169.48 94.68 0.11 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.03 86.79 1.64 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.638 2.225 . . . . 0.0 110.944 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.9 77.92 1.38 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.59 -63.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.692 2.261 . . . . 0.0 110.549 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.27 116.14 12.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 109.903 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.34 179.37 2.99 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.259 -1.142 . . . . 0.0 109.376 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.591 ' N ' ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -93.04 -30.73 15.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 0.0 109.369 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 67.19 59.44 0.53 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.48 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 tt -71.28 -7.25 45.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.635 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -88.31 -5.08 58.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.18 -0.95 . . . . 0.0 109.399 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.66 41.06 1.02 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 12' ' ' VAL . 2.7 p -112.93 93.89 2.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.708 -0.62 . . . . 0.0 109.925 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 12' ' ' VAL . 8.6 tp10 44.47 51.38 7.87 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.11 -0.994 . . . . 0.0 109.248 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 10' ' ' TYR . 1.4 mt -55.7 -179.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.353 -0.842 . . . . 0.0 109.631 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.71 -64.42 0.17 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.27 81.38 2.64 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.646 2.231 . . . . 0.0 110.285 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.71 -173.6 7.05 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.32 -63.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.663 2.242 . . . . 0.0 110.495 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 71.2 p -125.36 24.35 7.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.262 -0.899 . . . . 0.0 109.572 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.56 -148.82 14.49 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.252 -1.146 . . . . 0.0 109.423 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.25 -67.64 0.77 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.139 -0.976 . . . . 0.0 109.431 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 52.4 74.87 0.25 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.397 -0.815 . . . . 0.0 109.207 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.462 ' O ' HG12 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -90.97 -145.52 0.19 Allowed 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.135 -0.978 . . . . 0.0 109.364 -179.742 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.513 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -70.59 -1.98 12.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.137 -0.977 . . . . 0.0 110.342 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.408 ' N ' ' HD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -94.14 31.6 1.65 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.132 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.616 ' O ' HG22 ' A' ' 12' ' ' VAL . 2.6 p -96.97 75.91 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 14' ' ' LEU . 1.0 OUTLIER 47.19 53.04 11.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.17 -0.956 . . . . 0.0 109.213 -179.657 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.534 ' CD2' ' N ' ' A' ' 14' ' ' LEU . 0.4 OUTLIER -48.26 178.13 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.392 -0.817 . . . . 0.0 110.004 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.2 -78.85 0.09 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -80.8 -165.33 0.33 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.731 2.287 . . . . 0.0 110.746 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -166.31 -156.28 9.4 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.66 -9.69 15.86 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.62 2.213 . . . . 0.0 110.48 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.49 -92.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 109.581 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 21' ' ' ASP . . . -104.78 -159.2 23.65 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 1.6 m-20 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.278 -1.131 . . . . 0.0 109.512 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 m120 . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.233 0.539 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.1 -47.99 9.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.015 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.438 ' HA ' ' OE1' ' A' ' 8' ' ' GLU . 4.2 mm-40 -106.42 65.43 0.68 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.469 -0.769 . . . . 0.0 109.276 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 tt -86.04 8.98 18.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 109.493 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.548 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -87.41 -8.01 57.05 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.317 -0.864 . . . . 0.0 109.63 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.12 40.06 0.99 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.684 ' O ' HG22 ' A' ' 12' ' ' VAL . 2.2 p -106.63 75.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.392 0.615 . . . . 0.0 109.96 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 12' ' ' VAL . 60.7 mt-10 43.9 44.0 5.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.289 -0.882 . . . . 0.0 109.591 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 1.013 HD23 ' N ' ' A' ' 15' ' ' GLY . 5.2 tt -47.8 153.07 0.65 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.27 -0.894 . . . . 0.0 109.427 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 1.013 ' N ' HD23 ' A' ' 14' ' ' LEU . . . 165.6 168.32 27.59 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.3 81.27 2.78 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.758 2.305 . . . . 0.0 110.415 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.32 174.58 3.61 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.74 -3.16 13.28 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.549 2.166 . . . . 0.0 110.321 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.7 m -135.75 163.63 29.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.241 -0.912 . . . . 0.0 109.409 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.79 -151.99 23.65 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.8 t70 . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.274 -1.133 . . . . 0.0 109.351 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.515 ' HB2' HD12 ' A' ' 9' ' ' LEU . 1.3 t30 . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.11 -51.21 4.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.12 -0.987 . . . . 0.0 109.852 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -94.54 25.68 3.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.289 -0.882 . . . . 0.0 109.998 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.515 HD12 ' HB2' ' A' ' 6' ' ' ASN . 1.6 tt -72.86 -48.99 32.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.072 -1.017 . . . . 0.0 109.351 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.689 ' O ' HD21 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -75.99 -5.52 46.69 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.279 -0.888 . . . . 0.0 109.757 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -88.32 43.96 1.17 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 12' ' ' VAL . 3.5 p -116.96 78.85 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 121.376 0.608 . . . . 0.0 109.633 -178.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 50.37 74.66 0.21 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.106 -0.996 . . . . 0.0 109.14 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.689 HD21 ' O ' ' A' ' 10' ' ' TYR . 3.9 mm? -49.78 140.67 11.24 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.294 -0.879 . . . . 0.0 109.395 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.04 -94.64 0.49 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.54 75.27 5.04 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.651 2.234 . . . . 0.0 110.51 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.72 -157.32 32.61 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.4 -19.16 11.91 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.61 2.206 . . . . 0.0 110.419 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.9 p -102.24 80.18 1.94 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.286 -0.884 . . . . 0.0 109.457 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -156.56 -64.65 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 38.3 p-10 . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.346 -1.091 . . . . 0.0 109.54 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.418 ' OD1' ' HG2' ' A' ' 8' ' ' GLU . 21.6 t-20 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.405 ' O ' ' C ' ' A' ' 8' ' ' GLU . 0.1 OUTLIER -77.73 -46.03 22.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.151 -0.968 . . . . 0.0 108.786 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.418 ' HG2' ' OD1' ' A' ' 6' ' ' ASN . 0.2 OUTLIER 45.28 36.17 2.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.404 -0.81 . . . . 0.0 109.361 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.458 ' HB3' ' CD1' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -103.97 -58.52 1.87 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.188 -0.945 . . . . 0.0 109.457 -179.859 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.591 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -84.62 -3.13 58.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.922 . . . . 0.0 109.558 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -90.0 42.58 1.1 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.638 ' O ' HG22 ' A' ' 12' ' ' VAL . 3.4 p -114.38 70.31 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.735 -0.603 . . . . 0.0 110.055 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 53.45 61.68 3.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 0.0 109.544 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.512 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 10.3 mt -66.49 175.19 2.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.342 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.81 152.04 36.26 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.38 80.15 2.98 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.642 2.228 . . . . 0.0 110.442 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.34 169.8 54.6 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.89 -65.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.617 2.212 . . . . 0.0 110.382 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.5 m -142.24 139.61 32.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.202 -0.936 . . . . 0.0 109.47 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 117.5 -148.57 18.72 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.267 -1.137 . . . . 0.0 109.409 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.72 -30.56 11.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -0.941 . . . . 0.0 109.658 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.4 8.89 17.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -0.943 . . . . 0.0 109.982 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 tt -67.17 -31.74 72.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.013 -1.055 . . . . 0.0 109.292 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.44 6.31 23.87 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.199 -0.938 . . . . 0.0 109.347 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.428 ' HA ' ' OE1' ' A' ' 11' ' ' GLN . 11.3 tp60 -92.07 38.55 1.0 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.551 ' O ' HG22 ' A' ' 12' ' ' VAL . 2.5 p -105.06 83.07 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.823 -0.548 . . . . 0.0 110.063 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 14' ' ' LEU . 3.3 mm-40 51.9 28.72 5.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.239 -0.913 . . . . 0.0 109.686 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.502 HD23 ' O ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -48.72 176.61 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.07 -1.019 . . . . 0.0 109.478 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.36 153.77 6.58 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.29 79.2 3.36 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.656 2.237 . . . . 0.0 110.465 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -159.84 -88.65 0.07 OUTLIER Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.42 -1.36 11.53 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.594 2.196 . . . . 0.0 110.126 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.74 177.01 7.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.93 . . . . 0.0 109.467 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -142.64 -161.62 8.88 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.274 -1.133 . . . . 0.0 109.585 179.87 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.679 HD21 ' N ' ' A' ' 6' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 121.245 0.545 . . . . 0.0 109.683 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -93.85 -31.69 14.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.276 -0.89 . . . . 0.0 109.238 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 53.43 32.26 13.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.418 -0.801 . . . . 0.0 109.515 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.417 HD22 ' HA ' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -81.84 -70.64 0.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.614 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -79.28 4.66 14.45 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.1 -1.0 . . . . 0.0 109.573 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -88.32 40.29 0.95 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 12' ' ' VAL . 3.4 p -118.81 98.84 6.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.682 -0.636 . . . . 0.0 110.144 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 12' ' ' VAL . 0.3 OUTLIER 42.54 56.54 3.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.094 -1.004 . . . . 0.0 109.715 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 13' ' ' GLU . 4.9 mt -46.36 169.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.575 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -165.11 95.71 0.12 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.76 74.33 5.26 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.526 2.151 . . . . 0.0 110.719 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.14 74.76 1.28 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.37 -75.03 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.581 2.187 . . . . 0.0 110.156 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.02 -16.54 12.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.461 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -147.75 -179.51 23.81 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.312 -1.11 . . . . 0.0 109.601 -180.0 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtt . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.34 0.59 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.17 -69.78 2.07 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 1.0 OUTLIER -77.33 -27.61 52.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -1.156 . . . . 0.0 109.599 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 3' ' ' LYS . . . 61.09 151.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.133 -0.979 . . . . 0.0 109.356 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -136.44 158.82 43.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -0.893 . . . . 0.0 109.516 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.494 ' HB3' ' HB2' ' A' ' 9' ' ' LEU . 3.6 t-20 -99.27 -176.94 3.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 109.58 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -92.26 -55.43 3.42 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.333 -0.854 . . . . 0.0 109.363 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -127.91 53.14 1.8 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.387 -0.821 . . . . 0.0 109.57 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.749 ' C ' HD13 ' A' ' 9' ' ' LEU . 3.5 tm? -88.97 -71.36 0.6 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 109.442 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.542 ' CD1' ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -76.42 4.18 9.59 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.301 -0.874 . . . . 0.0 110.333 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.06 32.67 0.74 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.746 ' O ' HG22 ' A' ' 12' ' ' VAL . 2.3 p -105.95 68.95 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.698 -0.626 . . . . 0.0 109.524 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 49.74 55.77 8.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.329 -0.857 . . . . 0.0 109.429 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' A' ' 15' ' ' GLY . 0.8 OUTLIER -56.04 173.23 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 109.414 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.412 ' HA3' ' SD ' ' A' ' 22' ' ' MET . . . 55.29 100.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.91 78.49 3.55 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.425 2.083 . . . . 0.0 110.291 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.51 80.06 0.34 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.26 -81.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.671 2.247 . . . . 0.0 110.43 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.4 t -57.54 132.51 53.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 109.612 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.95 -147.45 49.46 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.27 -174.9 2.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.305 -1.115 . . . . 0.0 109.517 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.656 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 5.7 ttt -110.99 156.46 21.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.37 -0.831 . . . . 0.0 109.419 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 22' ' ' MET . . . 167.67 67.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 0.0 109.517 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.43 16.47 24.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.901 . . . . 0.0 109.387 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.0 mptt 52.3 68.48 0.81 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.528 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.8 tpt -149.13 -60.14 0.22 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.167 -0.958 . . . . 0.0 109.312 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.4 p -124.91 91.15 3.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.507 -0.745 . . . . 0.0 109.229 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.65 81.02 1.38 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.686 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.22 57.28 1.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.38 -0.825 . . . . 0.0 109.259 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.508 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -67.12 -67.76 0.43 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.604 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 30' ' ' LYS . . . 174.93 74.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.324 -0.86 . . . . 0.0 109.483 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.73 -97.55 0.02 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.8 ptt180 -98.49 -170.42 1.95 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -1.15 . . . . 0.0 109.443 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 CA-C-O 118.05 -1.417 . . . . 0.0 109.604 179.979 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.4 ttp . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.39 31.76 2.72 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt 58.6 63.93 1.57 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -1.144 . . . . 0.0 109.467 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -115.25 111.47 20.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.343 -0.848 . . . . 0.0 109.413 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.11 156.31 27.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 109.426 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -133.48 -45.94 0.82 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.334 -0.854 . . . . 0.0 109.342 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -98.48 -25.76 14.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.458 -0.776 . . . . 0.0 109.408 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -91.3 47.23 1.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.14 -0.975 . . . . 0.0 109.576 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.7 tt -82.04 -19.93 39.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.161 -0.962 . . . . 0.0 109.439 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.409 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -80.92 6.6 12.8 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.228 -0.92 . . . . 0.0 109.504 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.42 34.7 0.95 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.74 ' O ' HG22 ' A' ' 12' ' ' VAL . 2.2 p -101.54 71.29 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.832 -0.542 . . . . 0.0 109.603 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 14' ' ' LEU . 1.3 tt0 54.75 46.38 24.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.314 -0.866 . . . . 0.0 109.534 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.8 OUTLIER -46.15 171.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 109.336 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.09 137.76 41.09 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.29 78.97 3.43 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.436 2.09 . . . . 0.0 110.521 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.51 178.04 16.63 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.413 ' C ' ' OG ' ' A' ' 19' ' ' SER . 35.9 Cg_endo -78.6 -58.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.662 2.242 . . . . 0.0 110.408 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.413 ' OG ' ' C ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER 62.84 35.46 13.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -0.95 . . . . 0.0 109.369 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.84 -108.82 3.28 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.44 169.98 8.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.228 -1.16 . . . . 0.0 109.461 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.634 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 7.9 mtt -68.25 109.21 3.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.906 . . . . 0.0 109.407 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.634 ' HB2' ' O ' ' A' ' 22' ' ' MET . . . 168.48 83.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.279 -0.888 . . . . 0.0 109.458 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.09 151.3 19.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.413 ' O ' ' O ' ' A' ' 26' ' ' MET . 1.3 mttp -153.55 84.83 1.18 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.35 -0.844 . . . . 0.0 109.426 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.413 ' O ' ' O ' ' A' ' 25' ' ' LYS . 1.3 ttt 62.79 134.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.494 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.76 112.63 24.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.322 -0.861 . . . . 0.0 109.494 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.58 89.45 1.77 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.235 -0.916 . . . . 0.0 109.49 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp -172.08 -70.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 0.0 109.543 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -138.45 159.92 40.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.164 -0.96 . . . . 0.0 109.461 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 30' ' ' LYS . . . -48.66 176.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.282 -0.886 . . . . 0.0 109.538 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -123.46 -175.19 14.41 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -87.69 147.52 25.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.156 -1.203 . . . . 0.0 109.463 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 CA-C-O 117.94 -1.478 . . . . 0.0 109.568 -179.94 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 ttm . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.307 0.575 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.87 29.7 46.15 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.56 80.73 1.37 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -1.16 . . . . 0.0 109.644 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.53 117.98 28.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -0.929 . . . . 0.0 109.392 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -117.97 -49.71 2.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.137 -0.977 . . . . 0.0 109.571 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -58.66 150.74 22.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 109.527 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.28 -34.77 17.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.347 -0.846 . . . . 0.0 109.144 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.45 ' OE1' ' OE1' ' A' ' 11' ' ' GLN . 2.2 mt-10 -88.63 38.98 0.9 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.415 -0.803 . . . . 0.0 109.534 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.576 HD13 ' O ' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -71.18 -58.48 3.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -0.946 . . . . 0.0 109.232 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.518 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -82.88 7.21 15.95 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.221 -0.925 . . . . 0.0 109.387 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.45 ' OE1' ' OE1' ' A' ' 8' ' ' GLU . 4.8 tt0 -89.86 36.94 0.86 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.965 . . . . 0.0 108.415 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.508 ' O ' HG22 ' A' ' 12' ' ' VAL . 2.9 p -110.59 79.99 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.725 -0.609 . . . . 0.0 109.603 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 14' ' ' LEU . 1.1 tt0 50.11 71.23 0.42 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.083 -1.01 . . . . 0.0 108.821 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.519 ' HA ' HD13 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -42.27 161.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.339 -0.851 . . . . 0.0 109.71 -179.556 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.04 -67.07 0.04 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.15 74.44 5.32 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.657 2.238 . . . . 0.0 110.255 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.75 155.27 20.79 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -80.58 42.87 1.41 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.775 2.317 . . . . 0.0 110.592 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.0 p -59.61 123.2 16.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 109.553 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.3 -141.34 6.24 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -104.46 99.4 9.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -1.144 . . . . 0.0 109.466 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.567 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 0.6 OUTLIER -83.45 -58.57 2.77 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.164 -0.96 . . . . 0.0 109.532 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.665 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . 67.94 98.41 0.06 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.174 -0.953 . . . . 0.0 109.384 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 23' ' ' ALA . . . 72.91 173.53 0.3 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.196 -0.94 . . . . 0.0 109.47 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 67.17 96.19 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.932 . . . . 0.0 109.427 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 17.4 ttt -139.31 86.94 2.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.183 -0.948 . . . . 0.0 109.566 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 67.7 m -116.65 111.51 19.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.942 . . . . 0.0 109.406 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 27' ' ' SER . 2.5 mmmm 65.32 137.76 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.299 -0.875 . . . . 0.0 109.364 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.72 23.27 14.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.124 -0.985 . . . . 0.0 109.577 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -87.49 164.21 16.27 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.298 -0.876 . . . . 0.0 109.343 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.3 92.15 9.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 109.574 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.5 -170.58 20.43 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -178.9 134.04 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.209 -1.171 . . . . 0.0 109.498 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 CA-C-O 118.017 -1.435 . . . . 0.0 109.651 179.991 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -102.7 69.86 0.32 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -73.77 -23.76 59.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.306 -1.114 . . . . 0.0 109.361 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.77 -173.03 3.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.451 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.25 98.06 11.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.414 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.38 169.17 8.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.225 -0.922 . . . . 0.0 109.539 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.509 ' N ' ' CD1' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -89.5 -63.87 1.22 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.279 -0.888 . . . . 0.0 109.423 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 7' ' ' TYR . 11.8 mt-10 64.12 65.25 0.69 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.435 -0.79 . . . . 0.0 109.391 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.492 HD23 ' O ' ' A' ' 9' ' ' LEU . 4.6 tt -120.19 -47.61 2.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.184 -0.947 . . . . 0.0 109.329 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.449 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -84.34 10.82 9.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.276 -0.89 . . . . 0.0 109.268 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.97 32.89 0.88 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 12' ' ' VAL . 3.7 p -109.96 76.63 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 121.383 0.611 . . . . 0.0 109.457 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 51.93 63.6 2.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.119 -0.988 . . . . 0.0 109.284 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 14' ' ' LEU . 5.1 mt -45.64 165.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.351 -0.843 . . . . 0.0 109.659 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.2 -90.8 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.61 -164.87 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.804 2.336 . . . . 0.0 110.45 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.407 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 151.36 -94.96 0.15 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.407 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 35.4 Cg_endo -77.85 -24.97 8.09 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.53 2.153 . . . . 0.0 110.507 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.01 -168.32 1.88 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.31 -0.869 . . . . 0.0 109.476 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 21' ' ' ASP . . . -68.09 -101.41 0.03 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.502 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 15.8 t70 74.68 87.0 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -1.126 . . . . 0.0 109.545 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.52 -44.51 14.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.172 -0.955 . . . . 0.0 109.334 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -162.94 78.31 0.46 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.34 -0.85 . . . . 0.0 109.31 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.17 98.89 11.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.26 -0.9 . . . . 0.0 109.673 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.434 ' HE2' ' O ' ' A' ' 26' ' ' MET . 0.0 OUTLIER 56.92 69.46 0.74 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 0.0 109.551 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.434 ' O ' ' HE2' ' A' ' 25' ' ' LYS . 1.8 ttp -48.4 112.55 0.61 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.911 . . . . 0.0 109.436 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.62 142.11 30.9 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.354 -0.841 . . . . 0.0 109.444 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -154.31 128.61 9.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -0.885 . . . . 0.0 109.542 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 64.11 119.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.249 -0.907 . . . . 0.0 109.646 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.1 -37.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.922 . . . . 0.0 109.232 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.28 -34.79 14.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 109.295 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.11 174.74 29.46 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.74 42.04 1.22 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.253 -1.145 . . . . 0.0 109.609 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mtp . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 113.61 120.22 3.59 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.6 mttt 58.58 -177.38 0.08 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.204 -1.174 . . . . 0.0 109.616 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.73 -72.21 0.33 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.274 -0.891 . . . . 0.0 109.233 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -94.53 150.79 19.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 0.0 109.145 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 7' ' ' TYR . 0.9 OUTLIER -154.53 -49.84 0.09 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.096 -1.002 . . . . 0.0 109.774 -179.703 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.506 ' CE2' HG21 ' A' ' 12' ' ' VAL . 2.6 m-85 -40.81 165.48 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.243 -0.911 . . . . 0.0 110.712 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 7' ' ' TYR . 0.8 OUTLIER -157.04 -101.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.54 -0.725 . . . . 0.0 109.537 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.589 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -127.69 -131.22 0.23 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.956 -1.09 . . . . 0.0 108.827 -179.721 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.589 ' N ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -68.01 -1.66 6.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.686 -1.259 . . . . 0.0 110.616 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.419 ' N ' ' HD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -91.49 32.01 1.11 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.792 -1.193 . . . . 0.0 108.166 179.19 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 9' ' ' LEU . 3.1 p -105.72 98.97 7.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 121.299 0.571 . . . . 0.0 109.78 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER 48.54 31.05 2.69 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.164 -0.96 . . . . 0.0 109.405 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -50.24 179.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.286 -0.884 . . . . 0.0 109.701 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -123.8 -76.45 0.32 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -76.87 80.48 2.82 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.652 2.234 . . . . 0.0 110.627 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -103.81 -149.77 20.76 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.06 -34.11 1.81 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.411 2.074 . . . . 0.0 110.087 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -122.24 165.87 15.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.366 -0.834 . . . . 0.0 109.189 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.43 -97.14 0.89 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -85.39 46.06 1.25 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -1.153 . . . . 0.0 109.893 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.93 144.24 57.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.939 . . . . 0.0 109.125 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -147.17 85.7 1.61 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.099 -1.0 . . . . 0.0 109.738 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -123.45 16.46 9.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.844 . . . . 0.0 109.439 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.46 ' O ' ' HD2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -165.07 76.46 0.28 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.847 . . . . 0.0 109.351 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -151.03 137.67 18.79 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.28 -0.887 . . . . 0.0 109.409 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.31 179.85 6.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.249 -0.907 . . . . 0.0 109.466 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.32 86.21 1.82 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.381 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.5 tptm -157.42 60.11 0.5 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 109.465 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.425 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -84.63 -22.37 29.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.218 -0.926 . . . . 0.0 109.341 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . 60.79 153.62 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.465 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.47 90.33 0.08 OUTLIER Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 47.99 24.49 0.63 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -1.131 . . . . 0.0 109.487 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.939 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.31 0.576 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.95 143.47 4.85 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -139.46 160.13 40.55 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.305 -1.114 . . . . 0.0 109.591 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -173.11 61.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.117 -0.989 . . . . 0.0 109.497 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -148.74 63.73 1.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.314 -0.866 . . . . 0.0 109.498 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -146.32 112.06 5.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -0.892 . . . . 0.0 109.525 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -96.03 -78.79 0.45 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.39 -0.819 . . . . 0.0 109.31 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 7' ' ' TYR . 18.2 mt-10 42.12 44.55 3.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 109.705 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.787 HD23 ' N ' ' A' ' 10' ' ' TYR . 10.2 tt -67.33 -86.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.416 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.787 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -74.88 3.72 7.7 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.912 -1.117 . . . . 0.0 110.531 -179.77 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.406 ' N ' ' HD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -93.58 32.63 1.36 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.019 -1.051 . . . . 0.0 108.187 179.139 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.504 ' O ' HG22 ' A' ' 12' ' ' VAL . 2.4 p -101.98 87.19 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.66 -0.65 . . . . 0.0 110.008 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 12' ' ' VAL . 16.4 mm-40 44.54 48.45 8.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.135 -0.978 . . . . 0.0 109.349 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 10' ' ' TYR . 1.7 mt -47.48 151.4 0.79 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.386 -0.821 . . . . 0.0 109.514 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -109.56 156.83 15.42 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.9 82.46 2.42 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.641 2.227 . . . . 0.0 110.491 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.91 167.12 22.4 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.49 -41.21 0.27 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.606 2.204 . . . . 0.0 110.452 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.7 t -84.21 149.55 26.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -0.85 . . . . 0.0 109.478 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 21' ' ' ASP . . . -164.06 -162.83 15.7 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.44 ' O ' ' O ' ' A' ' 20' ' ' GLY . 8.3 m-20 60.95 122.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -1.145 . . . . 0.0 109.45 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 5.9 mtp -95.62 83.44 3.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.49 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -121.41 62.48 0.91 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.375 -0.828 . . . . 0.0 109.41 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -171.68 -38.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 109.606 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -129.48 63.92 1.5 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 109.62 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.4 ttt -102.15 172.9 6.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.206 -0.934 . . . . 0.0 109.354 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.17 179.81 6.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.256 -0.903 . . . . 0.0 109.729 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.74 100.22 13.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.31 -0.869 . . . . 0.0 109.532 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 16.2 pttm -128.44 126.79 41.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.186 -0.946 . . . . 0.0 109.374 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 32' ' ' GLY . 32.1 mmtp -105.82 -165.55 1.12 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.319 -0.863 . . . . 0.0 109.448 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.54 91.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.527 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 30' ' ' LYS . . . -132.26 160.46 23.68 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.34 109.17 6.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.223 -1.163 . . . . 0.0 109.476 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 CA-C-O 118.01 -1.439 . . . . 0.0 109.556 -179.847 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.252 0.549 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.62 -154.38 30.59 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -80.24 104.96 11.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -1.208 . . . . 0.0 109.441 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -157.69 152.55 25.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -0.891 . . . . 0.0 109.345 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.71 -65.49 0.98 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.158 -0.964 . . . . 0.0 109.603 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.522 ' O ' ' CB ' ' A' ' 11' ' ' GLN . 9.7 m-20 -73.47 111.03 8.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 109.807 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.59 -30.46 16.36 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.178 -0.951 . . . . 0.0 109.137 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -113.3 15.63 19.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.326 -0.859 . . . . 0.0 109.879 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.664 HD23 ' H ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -104.84 -142.24 0.37 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.021 -1.049 . . . . 0.0 109.266 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.664 ' H ' HD23 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -65.0 -6.19 8.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.111 -0.993 . . . . 0.0 110.47 -179.553 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.522 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 1.0 OUTLIER -90.4 40.39 1.01 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.957 -1.089 . . . . 0.0 108.126 179.254 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.8 p -113.31 85.62 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.783 -0.573 . . . . 0.0 109.754 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER 45.44 75.77 0.1 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.005 -1.059 . . . . 0.0 108.951 -179.607 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 13' ' ' GLU . 3.4 mm? -44.2 169.07 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.362 -0.836 . . . . 0.0 109.689 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.01 176.6 23.97 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.48 86.66 1.64 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.612 2.208 . . . . 0.0 110.532 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 61.15 86.69 0.04 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.19 -70.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.617 2.211 . . . . 0.0 110.512 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.3 p -175.37 93.91 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.136 -0.978 . . . . 0.0 109.659 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 142.64 -132.92 5.32 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.2 p30 -83.83 178.05 8.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.203 -1.175 . . . . 0.0 109.528 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 6.6 ttm -143.05 -163.37 1.62 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 109.518 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 46.3 71.98 0.26 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 109.5 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -122.91 65.07 0.97 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.397 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.36 80.38 1.35 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.47 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.52 116.04 4.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.301 -0.875 . . . . 0.0 109.304 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.83 125.68 2.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.183 -0.948 . . . . 0.0 109.743 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -119.05 140.47 49.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.268 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -145.57 -49.93 0.24 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.093 -1.004 . . . . 0.0 109.717 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.616 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -172.48 74.82 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 109.559 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 30' ' ' LYS . . . 168.85 70.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.46 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.62 111.62 4.32 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -102.3 135.76 43.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -1.143 . . . . 0.0 109.463 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 CA-C-O 117.903 -1.498 . . . . 0.0 109.526 179.999 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.293 0.568 . . . . 0.0 109.571 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 154.05 -140.87 7.8 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -150.88 152.36 33.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -1.121 . . . . 0.0 109.368 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.55 112.34 5.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.331 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -75.68 82.3 2.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.547 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -113.15 -43.77 3.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.359 -0.838 . . . . 0.0 109.485 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.91 -66.74 0.85 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 109.23 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 45.89 72.52 0.22 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.485 -0.76 . . . . 0.0 109.453 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.535 HD23 ' H ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -96.47 -139.37 0.27 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.889 . . . . 0.0 109.147 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.535 ' H ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -68.63 -2.67 9.6 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.942 -1.099 . . . . 0.0 110.499 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.478 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.9 OUTLIER -90.28 34.05 0.88 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.229 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.492 ' O ' HG22 ' A' ' 12' ' ' VAL . 3.4 p -103.77 78.02 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.355 0.597 . . . . 0.0 109.496 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER 56.41 64.99 1.53 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.074 -1.016 . . . . 0.0 108.816 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -48.52 -179.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.411 -0.805 . . . . 0.0 109.862 -179.542 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -169.48 94.68 0.11 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.03 86.79 1.64 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.638 2.225 . . . . 0.0 110.944 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.9 77.92 1.38 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.59 -63.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.692 2.261 . . . . 0.0 110.549 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.27 116.14 12.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 109.903 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.34 179.37 2.99 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -129.33 54.69 1.8 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -1.142 . . . . 0.0 109.376 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.557 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -126.0 57.91 1.36 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 109.497 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 22' ' ' MET . . . 172.19 84.9 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.297 -0.877 . . . . 0.0 109.573 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.28 -59.03 4.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.196 -0.94 . . . . 0.0 109.265 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 50.71 79.01 0.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.655 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.418 ' O ' ' CB ' ' A' ' 27' ' ' SER . 7.1 mtt -133.79 168.95 17.8 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.327 -0.858 . . . . 0.0 109.401 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.5 OUTLIER 68.74 -178.63 0.22 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.889 . . . . 0.0 109.361 -179.858 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 27' ' ' SER . 0.3 OUTLIER 69.18 163.83 0.24 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 109.479 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.93 166.29 22.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 0.0 109.519 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.51 67.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.9 . . . . 0.0 109.556 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.67 124.22 15.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.068 -1.02 . . . . 0.0 109.455 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.82 75.37 0.27 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -62.89 -58.95 5.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -1.148 . . . . 0.0 109.534 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 CA-C-O 117.933 -1.482 . . . . 0.0 109.554 179.945 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mtm . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.7 -179.74 29.83 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -102.66 70.74 1.14 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.357 -1.084 . . . . 0.0 109.422 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . -116.79 42.21 2.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.344 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 4' ' ' ALA . 1.7 mt-10 65.11 144.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.473 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -92.48 151.1 20.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 109.441 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.591 ' N ' ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -93.04 -30.73 15.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 0.0 109.369 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 67.19 59.44 0.53 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.48 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 tt -71.28 -7.25 45.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.635 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -88.31 -5.08 58.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.18 -0.95 . . . . 0.0 109.399 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.66 41.06 1.02 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 12' ' ' VAL . 2.7 p -112.93 93.89 2.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.708 -0.62 . . . . 0.0 109.925 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 12' ' ' VAL . 8.6 tp10 44.47 51.38 7.87 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.11 -0.994 . . . . 0.0 109.248 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 10' ' ' TYR . 1.4 mt -55.7 -179.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.353 -0.842 . . . . 0.0 109.631 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.71 -64.42 0.17 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.27 81.38 2.64 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.646 2.231 . . . . 0.0 110.285 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.71 -173.6 7.05 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.32 -63.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.663 2.242 . . . . 0.0 110.495 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 71.2 p -125.36 24.35 7.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.262 -0.899 . . . . 0.0 109.572 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.56 -148.82 14.49 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.52 -64.94 0.66 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -1.146 . . . . 0.0 109.423 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.541 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 15.7 mtt -81.67 150.42 28.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 109.542 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 22' ' ' MET . . . 173.55 69.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.229 -0.92 . . . . 0.0 109.472 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 23' ' ' ALA . . . 64.71 109.74 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.881 . . . . 0.0 109.521 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -170.01 60.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -0.951 . . . . 0.0 109.512 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.8 tpp -152.44 123.06 7.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 0.0 109.304 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.3 t -144.41 143.64 31.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.195 -0.941 . . . . 0.0 109.729 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -137.19 119.12 15.27 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.279 -0.888 . . . . 0.0 109.231 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 30' ' ' LYS . 0.5 OUTLIER -61.85 -175.73 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.523 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -44.43 120.86 2.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.669 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -126.73 118.42 24.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.882 . . . . 0.0 109.403 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.51 -118.7 0.02 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -42.47 78.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -1.139 . . . . 0.0 109.396 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 CA-C-O 117.967 -1.463 . . . . 0.0 109.596 -179.957 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.5 ptm . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.06 -140.83 21.1 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.584 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 1.5 pttt -158.83 68.84 0.46 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -1.185 . . . . 0.0 109.593 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 3' ' ' LYS . . . 69.14 -177.43 0.21 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 109.713 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 178.51 -156.42 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.264 -0.897 . . . . 0.0 109.317 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -149.7 -174.58 4.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 0.0 109.402 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.25 -67.64 0.77 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.139 -0.976 . . . . 0.0 109.431 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 52.4 74.87 0.25 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.397 -0.815 . . . . 0.0 109.207 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.462 ' O ' HG12 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -90.97 -145.52 0.19 Allowed 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.135 -0.978 . . . . 0.0 109.364 -179.742 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.513 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -70.59 -1.98 12.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.137 -0.977 . . . . 0.0 110.342 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.408 ' N ' ' HD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -94.14 31.6 1.65 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.132 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.616 ' O ' HG22 ' A' ' 12' ' ' VAL . 2.6 p -96.97 75.91 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 14' ' ' LEU . 1.0 OUTLIER 47.19 53.04 11.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.17 -0.956 . . . . 0.0 109.213 -179.657 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.534 ' CD2' ' N ' ' A' ' 14' ' ' LEU . 0.4 OUTLIER -48.26 178.13 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.392 -0.817 . . . . 0.0 110.004 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.2 -78.85 0.09 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -80.8 -165.33 0.33 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.731 2.287 . . . . 0.0 110.746 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -166.31 -156.28 9.4 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.66 -9.69 15.86 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.62 2.213 . . . . 0.0 110.48 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.49 -92.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 109.581 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 21' ' ' ASP . . . -104.78 -159.2 23.65 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 1.6 m-20 69.46 128.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -1.131 . . . . 0.0 109.512 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.431 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 24.5 ttp -105.24 -44.32 4.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.18 -0.95 . . . . 0.0 109.47 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 22' ' ' MET . . . 61.54 60.3 1.69 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -0.849 . . . . 0.0 109.455 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -109.8 119.35 39.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.201 -0.937 . . . . 0.0 109.52 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 7.1 mmtp 66.05 72.8 0.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.292 -0.88 . . . . 0.0 109.524 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -159.44 127.27 4.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.303 -0.873 . . . . 0.0 109.277 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.5 m -130.1 176.65 7.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -0.982 . . . . 0.0 109.848 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 29' ' ' LYS . 4.3 mttt -149.44 175.59 11.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.359 -0.838 . . . . 0.0 109.131 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 28' ' ' LYS . 1.8 mtpt 61.32 125.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.141 -0.975 . . . . 0.0 109.527 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.29 38.35 0.86 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.893 . . . . 0.0 109.404 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.77 20.97 16.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 109.467 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -157.58 -49.4 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.99 19.83 19.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.163 -1.198 . . . . 0.0 109.561 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 CA-C-O 117.914 -1.492 . . . . 0.0 109.483 -179.979 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 ttt . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.6 136.19 0.31 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.29 43.33 10.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -1.122 . . . . 0.0 109.441 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -114.54 39.05 2.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.156 -0.965 . . . . 0.0 109.418 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -124.06 139.12 54.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.266 -0.896 . . . . 0.0 109.447 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -121.25 162.6 19.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 109.57 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.1 -47.99 9.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.015 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.438 ' HA ' ' OE1' ' A' ' 8' ' ' GLU . 4.2 mm-40 -106.42 65.43 0.68 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.469 -0.769 . . . . 0.0 109.276 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 tt -86.04 8.98 18.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 109.493 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.548 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -87.41 -8.01 57.05 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.317 -0.864 . . . . 0.0 109.63 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.12 40.06 0.99 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.684 ' O ' HG22 ' A' ' 12' ' ' VAL . 2.2 p -106.63 75.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.392 0.615 . . . . 0.0 109.96 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 12' ' ' VAL . 60.7 mt-10 43.9 44.0 5.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.289 -0.882 . . . . 0.0 109.591 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 1.013 HD23 ' N ' ' A' ' 15' ' ' GLY . 5.2 tt -47.8 153.07 0.65 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.27 -0.894 . . . . 0.0 109.427 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 1.013 ' N ' HD23 ' A' ' 14' ' ' LEU . . . 165.6 168.32 27.59 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.3 81.27 2.78 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.758 2.305 . . . . 0.0 110.415 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.32 174.58 3.61 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.74 -3.16 13.28 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.549 2.166 . . . . 0.0 110.321 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.7 m -135.75 163.63 29.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.241 -0.912 . . . . 0.0 109.409 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.79 -151.99 23.65 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -94.44 163.28 13.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.274 -1.133 . . . . 0.0 109.351 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 3.2 ttt -137.27 36.01 2.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.306 -0.871 . . . . 0.0 109.502 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.45 60.29 1.7 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.268 -0.895 . . . . 0.0 109.409 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 25' ' ' LYS . . . -140.14 -41.75 0.43 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.35 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 26' ' ' MET . 1.8 ttpm? 44.74 75.29 0.11 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.874 . . . . 0.0 109.699 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.447 ' O ' ' O ' ' A' ' 25' ' ' LYS . 0.3 OUTLIER 57.32 111.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 0.0 109.654 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.9 p -115.67 90.24 3.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.351 -0.843 . . . . 0.0 109.223 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.3 tttt -74.06 135.87 43.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.897 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp 45.43 81.35 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.302 -0.874 . . . . 0.0 109.842 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -75.29 113.3 12.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -0.929 . . . . 0.0 109.109 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.32 161.39 28.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.102 -0.999 . . . . 0.0 109.732 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 159.2 -161.24 31.9 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -127.99 86.74 2.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -1.193 . . . . 0.0 109.385 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 CA-C-O 117.974 -1.459 . . . . 0.0 109.535 179.974 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.483 ' O ' ' CB ' ' A' ' 3' ' ' LYS . . . 114.43 84.49 1.24 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER 73.25 43.29 0.39 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -1.146 . . . . 0.0 109.604 179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.14 109.18 14.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.58 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -160.76 50.12 0.26 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.529 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.515 ' HB2' HD12 ' A' ' 9' ' ' LEU . 1.3 t30 -94.62 -177.12 4.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.26 -0.9 . . . . 0.0 109.356 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.11 -51.21 4.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.12 -0.987 . . . . 0.0 109.852 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -94.54 25.68 3.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.289 -0.882 . . . . 0.0 109.998 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.515 HD12 ' HB2' ' A' ' 6' ' ' ASN . 1.6 tt -72.86 -48.99 32.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.072 -1.017 . . . . 0.0 109.351 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.689 ' O ' HD21 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -75.99 -5.52 46.69 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.279 -0.888 . . . . 0.0 109.757 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -88.32 43.96 1.17 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 12' ' ' VAL . 3.5 p -116.96 78.85 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 121.376 0.608 . . . . 0.0 109.633 -178.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 50.37 74.66 0.21 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.106 -0.996 . . . . 0.0 109.14 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.689 HD21 ' O ' ' A' ' 10' ' ' TYR . 3.9 mm? -49.78 140.67 11.24 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.294 -0.879 . . . . 0.0 109.395 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.04 -94.64 0.49 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.54 75.27 5.04 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.651 2.234 . . . . 0.0 110.51 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.72 -157.32 32.61 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.4 -19.16 11.91 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.61 2.206 . . . . 0.0 110.419 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.9 p -102.24 80.18 1.94 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.286 -0.884 . . . . 0.0 109.457 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -156.56 -64.65 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 38.3 p-10 -64.41 98.8 0.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -1.091 . . . . 0.0 109.54 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.449 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 0.6 OUTLIER -62.99 162.99 10.46 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.215 -0.928 . . . . 0.0 109.419 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 22' ' ' MET . . . 177.87 97.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 0.0 109.461 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.27 86.59 5.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.325 -0.859 . . . . 0.0 109.679 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt 54.17 76.18 0.25 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -0.886 . . . . 0.0 109.538 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 21.0 mtp -108.85 -168.59 1.36 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.41 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.9 m 49.31 74.98 0.17 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.327 -0.858 . . . . 0.0 109.512 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 ttpt -107.77 83.34 1.78 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.276 -0.89 . . . . 0.0 109.287 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.04 -95.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.488 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -153.15 -64.37 0.15 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.062 -1.024 . . . . 0.0 109.519 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.19 -73.1 0.5 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 0.0 109.649 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.89 49.43 3.12 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.64 88.83 3.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -1.126 . . . . 0.0 109.575 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.993 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ptt? . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.366 0.603 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -124.95 -177.87 15.08 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.407 ' O ' ' HG2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -53.68 140.69 28.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -1.15 . . . . 0.0 109.524 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -169.44 160.81 9.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.361 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -94.13 -21.18 19.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 109.509 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.418 ' OD1' ' HG2' ' A' ' 8' ' ' GLU . 21.6 t-20 -73.16 130.78 41.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 109.33 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.405 ' O ' ' C ' ' A' ' 8' ' ' GLU . 0.1 OUTLIER -77.73 -46.03 22.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.151 -0.968 . . . . 0.0 108.786 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.418 ' HG2' ' OD1' ' A' ' 6' ' ' ASN . 0.2 OUTLIER 45.28 36.17 2.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.404 -0.81 . . . . 0.0 109.361 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.458 ' HB3' ' CD1' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -103.97 -58.52 1.87 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.188 -0.945 . . . . 0.0 109.457 -179.859 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.591 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -84.62 -3.13 58.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.922 . . . . 0.0 109.558 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -90.0 42.58 1.1 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.638 ' O ' HG22 ' A' ' 12' ' ' VAL . 3.4 p -114.38 70.31 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.735 -0.603 . . . . 0.0 110.055 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 53.45 61.68 3.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 0.0 109.544 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.512 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 10.3 mt -66.49 175.19 2.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.342 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.81 152.04 36.26 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.38 80.15 2.98 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.642 2.228 . . . . 0.0 110.442 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.34 169.8 54.6 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.89 -65.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.617 2.212 . . . . 0.0 110.382 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.5 m -142.24 139.61 32.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.202 -0.936 . . . . 0.0 109.47 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 117.5 -148.57 18.72 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.498 ' O ' ' CG ' ' A' ' 22' ' ' MET . 0.9 OUTLIER 60.86 31.51 20.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -1.137 . . . . 0.0 109.409 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.498 ' CG ' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER 171.94 158.69 0.1 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 109.263 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 53.93 82.49 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.185 -0.947 . . . . 0.0 109.396 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.72 -158.79 0.21 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -0.893 . . . . 0.0 109.709 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.71 58.84 5.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.284 -0.885 . . . . 0.0 109.464 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -179.41 -170.35 0.17 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.889 . . . . 0.0 109.42 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 65.93 128.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.195 -0.94 . . . . 0.0 109.387 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 67.0 59.17 0.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.315 -0.866 . . . . 0.0 109.568 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.13 153.78 43.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 109.339 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.58 154.74 31.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.155 -0.966 . . . . 0.0 109.394 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.49 110.91 10.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.314 -0.866 . . . . 0.0 109.479 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.76 -152.04 11.95 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.57 -71.31 0.37 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.227 -1.161 . . . . 0.0 109.417 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 CA-C-O 117.985 -1.453 . . . . 0.0 109.469 -179.952 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.313 0.577 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.28 46.61 1.15 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 4' ' ' ALA . 1.1 mttm -121.93 45.15 2.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -1.163 . . . . 0.0 109.302 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 3' ' ' LYS . . . 44.51 87.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.278 -0.889 . . . . 0.0 109.397 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -158.33 145.31 17.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.244 -0.91 . . . . 0.0 109.536 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -143.77 154.98 44.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.388 -0.82 . . . . 0.0 109.371 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.72 -30.56 11.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -0.941 . . . . 0.0 109.658 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.4 8.89 17.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -0.943 . . . . 0.0 109.982 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 tt -67.17 -31.74 72.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.013 -1.055 . . . . 0.0 109.292 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.44 6.31 23.87 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.199 -0.938 . . . . 0.0 109.347 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.428 ' HA ' ' OE1' ' A' ' 11' ' ' GLN . 11.3 tp60 -92.07 38.55 1.0 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.551 ' O ' HG22 ' A' ' 12' ' ' VAL . 2.5 p -105.06 83.07 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.823 -0.548 . . . . 0.0 110.063 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 14' ' ' LEU . 3.3 mm-40 51.9 28.72 5.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.239 -0.913 . . . . 0.0 109.686 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.502 HD23 ' O ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -48.72 176.61 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.07 -1.019 . . . . 0.0 109.478 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.36 153.77 6.58 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.29 79.2 3.36 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.656 2.237 . . . . 0.0 110.465 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -159.84 -88.65 0.07 OUTLIER Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.42 -1.36 11.53 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.594 2.196 . . . . 0.0 110.126 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.74 177.01 7.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.93 . . . . 0.0 109.467 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -142.64 -161.62 8.88 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -147.24 -46.16 0.17 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -1.133 . . . . 0.0 109.585 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.83 98.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.337 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -170.06 89.25 0.16 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.191 -0.943 . . . . 0.0 109.655 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 58.6 105.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.626 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -157.08 77.41 0.87 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.295 -0.878 . . . . 0.0 109.348 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -179.79 77.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.314 -0.866 . . . . 0.0 109.309 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 28' ' ' LYS . 2.2 m -138.71 59.96 1.61 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.939 . . . . 0.0 109.503 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.453 ' O ' ' O ' ' A' ' 27' ' ' SER . 9.5 tttt 52.94 173.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.272 -0.893 . . . . 0.0 109.608 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -102.65 -14.31 16.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 109.555 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.456 ' O ' ' O ' ' A' ' 31' ' ' ALA . 1.4 ttmt 56.7 107.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.259 -0.901 . . . . 0.0 109.445 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 30' ' ' LYS . . . 61.15 137.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.266 -0.896 . . . . 0.0 109.479 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.12 37.66 3.26 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.07 27.25 2.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.281 -1.129 . . . . 0.0 109.471 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 CA-C-O 118.014 -1.437 . . . . 0.0 109.602 -179.972 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 148.19 104.6 0.35 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.5 pttt -145.21 141.37 28.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.211 -1.17 . . . . 0.0 109.415 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.52 72.77 1.49 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.448 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.54 140.35 26.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -70.8 146.6 49.64 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.278 -0.889 . . . . 0.0 109.683 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -93.85 -31.69 14.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.276 -0.89 . . . . 0.0 109.238 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 53.43 32.26 13.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.418 -0.801 . . . . 0.0 109.515 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.417 HD22 ' HA ' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -81.84 -70.64 0.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.614 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -79.28 4.66 14.45 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.1 -1.0 . . . . 0.0 109.573 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -88.32 40.29 0.95 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 12' ' ' VAL . 3.4 p -118.81 98.84 6.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.682 -0.636 . . . . 0.0 110.144 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 12' ' ' VAL . 0.3 OUTLIER 42.54 56.54 3.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.094 -1.004 . . . . 0.0 109.715 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 13' ' ' GLU . 4.9 mt -46.36 169.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.575 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -165.11 95.71 0.12 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.76 74.33 5.26 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.526 2.151 . . . . 0.0 110.719 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.14 74.76 1.28 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.37 -75.03 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.581 2.187 . . . . 0.0 110.156 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.02 -16.54 12.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.461 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -147.75 -179.51 23.81 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 61.98 150.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -1.11 . . . . 0.0 109.601 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.17 -67.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.572 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -171.93 72.53 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 109.477 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 25' ' ' LYS . . . -129.12 113.85 15.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.576 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 1.8 tmmt? 65.63 82.5 0.18 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.194 -0.941 . . . . 0.0 109.551 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.448 ' O ' ' HB3' ' A' ' 27' ' ' SER . 1.7 ttp -152.72 -44.3 0.1 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.199 -0.938 . . . . 0.0 109.392 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 26' ' ' MET . 68.7 p 174.95 165.43 0.27 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.409 -0.807 . . . . 0.0 109.302 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.39 115.82 13.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.227 -0.92 . . . . 0.0 109.689 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -141.33 164.77 29.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -0.829 . . . . 0.0 109.382 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt -107.62 59.36 0.62 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.172 -0.955 . . . . 0.0 109.521 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -85.29 153.09 22.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.218 -0.926 . . . . 0.0 109.404 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.66 151.97 28.4 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.58 154.24 17.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -1.124 . . . . 0.0 109.442 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 CA-C-O 118.049 -1.417 . . . . 0.0 109.563 -179.928 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.494 ' HB3' ' HB2' ' A' ' 9' ' ' LEU . 3.6 t-20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.266 0.555 . . . . 0.0 109.58 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -92.26 -55.43 3.42 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.333 -0.854 . . . . 0.0 109.363 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -127.91 53.14 1.8 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.387 -0.821 . . . . 0.0 109.57 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.749 HD13 ' C ' ' A' ' 9' ' ' LEU . 3.5 tm? -88.97 -71.36 0.6 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 109.442 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.542 ' CD1' ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -76.42 4.18 9.59 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.301 -0.874 . . . . 0.0 110.333 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.06 32.67 0.74 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.746 HG22 ' O ' ' A' ' 12' ' ' VAL . 2.3 p -105.95 68.95 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.698 -0.626 . . . . 0.0 109.524 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 49.74 55.77 8.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.329 -0.857 . . . . 0.0 109.429 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' A' ' 15' ' ' GLY . 0.8 OUTLIER -56.04 173.23 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 109.414 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 14' ' ' LEU . . . 55.29 100.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.91 78.49 3.55 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.425 2.083 . . . . 0.0 110.291 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.51 80.06 0.34 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.26 -81.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.671 2.247 . . . . 0.0 110.43 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.4 t -57.54 132.51 53.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 109.612 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.95 -147.45 49.46 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.305 -1.115 . . . . 0.0 109.517 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -98.48 -25.76 14.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.458 -0.776 . . . . 0.0 109.408 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -91.3 47.23 1.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.14 -0.975 . . . . 0.0 109.576 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.7 tt -82.04 -19.93 39.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.161 -0.962 . . . . 0.0 109.439 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.409 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -80.92 6.6 12.8 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.228 -0.92 . . . . 0.0 109.504 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.42 34.7 0.95 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.74 HG22 ' O ' ' A' ' 12' ' ' VAL . 2.2 p -101.54 71.29 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.832 -0.542 . . . . 0.0 109.603 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 14' ' ' LEU . 1.3 tt0 54.75 46.38 24.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.314 -0.866 . . . . 0.0 109.534 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.8 OUTLIER -46.15 171.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 109.336 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.09 137.76 41.09 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.29 78.97 3.43 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.436 2.09 . . . . 0.0 110.521 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.51 178.04 16.63 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.413 ' C ' ' OG ' ' A' ' 19' ' ' SER . 35.9 Cg_endo -78.6 -58.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.662 2.242 . . . . 0.0 110.408 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.413 ' OG ' ' C ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER 62.84 35.46 13.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -0.95 . . . . 0.0 109.369 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.84 -108.82 3.28 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.228 -1.16 . . . . 0.0 109.461 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.8 m120 . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.28 -34.77 17.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.347 -0.846 . . . . 0.0 109.144 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.45 ' OE1' ' OE1' ' A' ' 11' ' ' GLN . 2.2 mt-10 -88.63 38.98 0.9 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.415 -0.803 . . . . 0.0 109.534 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.576 HD13 ' O ' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -71.18 -58.48 3.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -0.946 . . . . 0.0 109.232 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.518 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -82.88 7.21 15.95 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.221 -0.925 . . . . 0.0 109.387 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.45 ' OE1' ' OE1' ' A' ' 8' ' ' GLU . 4.8 tt0 -89.86 36.94 0.86 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.965 . . . . 0.0 108.415 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 12' ' ' VAL . 2.9 p -110.59 79.99 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.725 -0.609 . . . . 0.0 109.603 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 14' ' ' LEU . 1.1 tt0 50.11 71.23 0.42 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.083 -1.01 . . . . 0.0 108.821 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.519 ' HA ' HD13 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -42.27 161.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.339 -0.851 . . . . 0.0 109.71 -179.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.04 -67.07 0.04 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.15 74.44 5.32 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.657 2.238 . . . . 0.0 110.255 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.75 155.27 20.79 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -80.58 42.87 1.41 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.775 2.317 . . . . 0.0 110.592 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.0 p -59.61 123.2 16.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 109.553 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.3 -141.34 6.24 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.255 -1.144 . . . . 0.0 109.466 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.387 0.613 . . . . 0.0 109.539 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.509 ' N ' ' CD1' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -89.5 -63.87 1.22 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.279 -0.888 . . . . 0.0 109.423 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 7' ' ' TYR . 11.8 mt-10 64.12 65.25 0.69 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.435 -0.79 . . . . 0.0 109.391 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.492 ' O ' HD23 ' A' ' 9' ' ' LEU . 4.6 tt -120.19 -47.61 2.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.184 -0.947 . . . . 0.0 109.329 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.449 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -84.34 10.82 9.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.276 -0.89 . . . . 0.0 109.268 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.97 32.89 0.88 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 12' ' ' VAL . 3.7 p -109.96 76.63 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 121.383 0.611 . . . . 0.0 109.457 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 51.93 63.6 2.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.119 -0.988 . . . . 0.0 109.284 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 14' ' ' LEU . 5.1 mt -45.64 165.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.351 -0.843 . . . . 0.0 109.659 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.2 -90.8 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.61 -164.87 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.804 2.336 . . . . 0.0 110.45 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.407 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 151.36 -94.96 0.15 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.407 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 35.4 Cg_endo -77.85 -24.97 8.09 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.53 2.153 . . . . 0.0 110.507 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.01 -168.32 1.88 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.31 -0.869 . . . . 0.0 109.476 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 21' ' ' ASP . . . -68.09 -101.41 0.03 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.502 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 15.8 t70 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.286 -1.126 . . . . 0.0 109.545 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 7' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.169 0.509 . . . . 0.0 109.774 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.506 ' CE2' HG21 ' A' ' 12' ' ' VAL . 2.6 m-85 -40.81 165.48 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.243 -0.911 . . . . 0.0 110.712 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 7' ' ' TYR . 0.8 OUTLIER -157.04 -101.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.54 -0.725 . . . . 0.0 109.537 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.589 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -127.69 -131.22 0.23 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.956 -1.09 . . . . 0.0 108.827 -179.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.589 ' N ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -68.01 -1.66 6.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.686 -1.259 . . . . 0.0 110.616 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.419 ' N ' ' HD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -91.49 32.01 1.11 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.792 -1.193 . . . . 0.0 108.166 179.19 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 9' ' ' LEU . 3.1 p -105.72 98.97 7.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 121.299 0.571 . . . . 0.0 109.78 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER 48.54 31.05 2.69 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.164 -0.96 . . . . 0.0 109.405 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -50.24 179.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.286 -0.884 . . . . 0.0 109.701 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -123.8 -76.45 0.32 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -76.87 80.48 2.82 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.652 2.234 . . . . 0.0 110.627 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -103.81 -149.77 20.76 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.06 -34.11 1.81 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.411 2.074 . . . . 0.0 110.087 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -122.24 165.87 15.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.366 -0.834 . . . . 0.0 109.189 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.43 -97.14 0.89 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.24 -1.153 . . . . 0.0 109.893 -179.672 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.0 t30 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -96.03 -78.79 0.45 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.39 -0.819 . . . . 0.0 109.31 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 7' ' ' TYR . 18.2 mt-10 42.12 44.55 3.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 109.705 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.787 HD23 ' N ' ' A' ' 10' ' ' TYR . 10.2 tt -67.33 -86.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.416 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.787 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -74.88 3.72 7.7 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.912 -1.117 . . . . 0.0 110.531 -179.77 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.406 ' N ' ' HD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -93.58 32.63 1.36 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.019 -1.051 . . . . 0.0 108.187 179.139 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 12' ' ' VAL . 2.4 p -101.98 87.19 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.66 -0.65 . . . . 0.0 110.008 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 12' ' ' VAL . 16.4 mm-40 44.54 48.45 8.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.135 -0.978 . . . . 0.0 109.349 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 10' ' ' TYR . 1.7 mt -47.48 151.4 0.79 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.386 -0.821 . . . . 0.0 109.514 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -109.56 156.83 15.42 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.9 82.46 2.42 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.641 2.227 . . . . 0.0 110.491 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.91 167.12 22.4 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.49 -41.21 0.27 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.606 2.204 . . . . 0.0 110.452 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.7 t -84.21 149.55 26.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -0.85 . . . . 0.0 109.478 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 21' ' ' ASP . . . -164.06 -162.83 15.7 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.44 ' O ' ' O ' ' A' ' 20' ' ' GLY . 8.3 m-20 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.254 -1.145 . . . . 0.0 109.45 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.522 ' O ' ' CB ' ' A' ' 11' ' ' GLN . 1.2 m120 . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.299 0.571 . . . . 0.0 109.807 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.59 -30.46 16.36 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.178 -0.951 . . . . 0.0 109.137 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -113.3 15.63 19.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.326 -0.859 . . . . 0.0 109.879 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.664 HD23 ' H ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -104.84 -142.24 0.37 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.021 -1.049 . . . . 0.0 109.266 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.664 ' H ' HD23 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -65.0 -6.19 8.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.111 -0.993 . . . . 0.0 110.47 -179.553 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.522 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 1.0 OUTLIER -90.4 40.39 1.01 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.957 -1.089 . . . . 0.0 108.126 179.254 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.8 p -113.31 85.62 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.783 -0.573 . . . . 0.0 109.754 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER 45.44 75.77 0.1 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.005 -1.059 . . . . 0.0 108.951 -179.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 13' ' ' GLU . 3.4 mm? -44.2 169.07 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.362 -0.836 . . . . 0.0 109.689 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.01 176.6 23.97 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.48 86.66 1.64 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.612 2.208 . . . . 0.0 110.532 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 61.15 86.69 0.04 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.19 -70.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.617 2.211 . . . . 0.0 110.512 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.3 p -175.37 93.91 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.136 -0.978 . . . . 0.0 109.659 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 142.64 -132.92 5.32 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.2 p30 . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.203 -1.175 . . . . 0.0 109.528 -179.964 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.329 0.585 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.91 -66.74 0.85 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 109.23 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 45.89 72.52 0.22 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.485 -0.76 . . . . 0.0 109.453 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.535 HD23 ' H ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -96.47 -139.37 0.27 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.889 . . . . 0.0 109.147 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.535 ' H ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -68.63 -2.67 9.6 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.942 -1.099 . . . . 0.0 110.499 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.478 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.9 OUTLIER -90.28 34.05 0.88 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.229 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 12' ' ' VAL . 3.4 p -103.77 78.02 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.355 0.597 . . . . 0.0 109.496 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER 56.41 64.99 1.53 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.074 -1.016 . . . . 0.0 108.816 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -48.52 -179.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.411 -0.805 . . . . 0.0 109.862 -179.542 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -169.48 94.68 0.11 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.03 86.79 1.64 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.638 2.225 . . . . 0.0 110.944 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.9 77.92 1.38 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.59 -63.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.692 2.261 . . . . 0.0 110.549 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.27 116.14 12.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 109.903 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.34 179.37 2.99 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 t70 . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.259 -1.142 . . . . 0.0 109.376 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.591 ' N ' ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -93.04 -30.73 15.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 0.0 109.369 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 67.19 59.44 0.53 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.48 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 tt -71.28 -7.25 45.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.635 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -88.31 -5.08 58.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.18 -0.95 . . . . 0.0 109.399 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.66 41.06 1.02 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 12' ' ' VAL . 2.7 p -112.93 93.89 2.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.708 -0.62 . . . . 0.0 109.925 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 12' ' ' VAL . 8.6 tp10 44.47 51.38 7.87 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.11 -0.994 . . . . 0.0 109.248 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 10' ' ' TYR . 1.4 mt -55.7 -179.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.353 -0.842 . . . . 0.0 109.631 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.71 -64.42 0.17 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.27 81.38 2.64 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.646 2.231 . . . . 0.0 110.285 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.71 -173.6 7.05 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.32 -63.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.663 2.242 . . . . 0.0 110.495 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 71.2 p -125.36 24.35 7.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.262 -0.899 . . . . 0.0 109.572 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.56 -148.82 14.49 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.252 -1.146 . . . . 0.0 109.423 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.25 -67.64 0.77 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.139 -0.976 . . . . 0.0 109.431 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 52.4 74.87 0.25 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.397 -0.815 . . . . 0.0 109.207 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.462 ' O ' HG12 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -90.97 -145.52 0.19 Allowed 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.135 -0.978 . . . . 0.0 109.364 -179.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.513 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -70.59 -1.98 12.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.137 -0.977 . . . . 0.0 110.342 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.408 ' N ' ' HD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -94.14 31.6 1.65 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 12' ' ' VAL . 2.6 p -96.97 75.91 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 14' ' ' LEU . 1.0 OUTLIER 47.19 53.04 11.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.17 -0.956 . . . . 0.0 109.213 -179.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.534 ' CD2' ' N ' ' A' ' 14' ' ' LEU . 0.4 OUTLIER -48.26 178.13 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.392 -0.817 . . . . 0.0 110.004 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.2 -78.85 0.09 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -80.8 -165.33 0.33 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.731 2.287 . . . . 0.0 110.746 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -166.31 -156.28 9.4 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.66 -9.69 15.86 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.62 2.213 . . . . 0.0 110.48 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.49 -92.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 109.581 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 21' ' ' ASP . . . -104.78 -159.2 23.65 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 1.6 m-20 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.278 -1.131 . . . . 0.0 109.512 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 m120 . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 121.233 0.539 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.1 -47.99 9.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.015 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.438 ' HA ' ' OE1' ' A' ' 8' ' ' GLU . 4.2 mm-40 -106.42 65.43 0.68 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.469 -0.769 . . . . 0.0 109.276 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 tt -86.04 8.98 18.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 109.493 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.548 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -87.41 -8.01 57.05 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.317 -0.864 . . . . 0.0 109.63 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.12 40.06 0.99 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 12' ' ' VAL . 2.2 p -106.63 75.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.392 0.615 . . . . 0.0 109.96 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 12' ' ' VAL . 60.7 mt-10 43.9 44.0 5.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.289 -0.882 . . . . 0.0 109.591 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 1.013 HD23 ' N ' ' A' ' 15' ' ' GLY . 5.2 tt -47.8 153.07 0.65 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.27 -0.894 . . . . 0.0 109.427 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 1.013 ' N ' HD23 ' A' ' 14' ' ' LEU . . . 165.6 168.32 27.59 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.3 81.27 2.78 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.758 2.305 . . . . 0.0 110.415 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.32 174.58 3.61 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.74 -3.16 13.28 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.549 2.166 . . . . 0.0 110.321 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.7 m -135.75 163.63 29.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.241 -0.912 . . . . 0.0 109.409 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.79 -151.99 23.65 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.8 t70 . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.274 -1.133 . . . . 0.0 109.351 -179.986 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.515 ' HB2' HD12 ' A' ' 9' ' ' LEU . 1.3 t30 . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.11 -51.21 4.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.12 -0.987 . . . . 0.0 109.852 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -94.54 25.68 3.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.289 -0.882 . . . . 0.0 109.998 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.515 HD12 ' HB2' ' A' ' 6' ' ' ASN . 1.6 tt -72.86 -48.99 32.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.072 -1.017 . . . . 0.0 109.351 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.689 ' O ' HD21 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -75.99 -5.52 46.69 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.279 -0.888 . . . . 0.0 109.757 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -88.32 43.96 1.17 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.519 ' O ' HG13 ' A' ' 12' ' ' VAL . 3.5 p -116.96 78.85 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 121.376 0.608 . . . . 0.0 109.633 -178.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 50.37 74.66 0.21 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.106 -0.996 . . . . 0.0 109.14 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.689 HD21 ' O ' ' A' ' 10' ' ' TYR . 3.9 mm? -49.78 140.67 11.24 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.294 -0.879 . . . . 0.0 109.395 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.04 -94.64 0.49 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.54 75.27 5.04 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.651 2.234 . . . . 0.0 110.51 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.72 -157.32 32.61 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.4 -19.16 11.91 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.61 2.206 . . . . 0.0 110.419 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.9 p -102.24 80.18 1.94 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.286 -0.884 . . . . 0.0 109.457 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -156.56 -64.65 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 38.3 p-10 . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.346 -1.091 . . . . 0.0 109.54 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.418 ' OD1' ' HG2' ' A' ' 8' ' ' GLU . 21.6 t-20 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.405 ' O ' ' C ' ' A' ' 8' ' ' GLU . 0.1 OUTLIER -77.73 -46.03 22.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.151 -0.968 . . . . 0.0 108.786 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.418 ' HG2' ' OD1' ' A' ' 6' ' ' ASN . 0.2 OUTLIER 45.28 36.17 2.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.404 -0.81 . . . . 0.0 109.361 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.458 ' HB3' ' CD1' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -103.97 -58.52 1.87 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.188 -0.945 . . . . 0.0 109.457 -179.859 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.591 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -84.62 -3.13 58.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.922 . . . . 0.0 109.558 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -90.0 42.58 1.1 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 12' ' ' VAL . 3.4 p -114.38 70.31 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.735 -0.603 . . . . 0.0 110.055 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 53.45 61.68 3.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 0.0 109.544 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.512 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 10.3 mt -66.49 175.19 2.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.342 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.81 152.04 36.26 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.38 80.15 2.98 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.642 2.228 . . . . 0.0 110.442 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.34 169.8 54.6 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.89 -65.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.617 2.212 . . . . 0.0 110.382 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.5 m -142.24 139.61 32.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.202 -0.936 . . . . 0.0 109.47 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 117.5 -148.57 18.72 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.267 -1.137 . . . . 0.0 109.409 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.72 -30.56 11.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -0.941 . . . . 0.0 109.658 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.4 8.89 17.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -0.943 . . . . 0.0 109.982 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 tt -67.17 -31.74 72.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.013 -1.055 . . . . 0.0 109.292 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.44 6.31 23.87 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.199 -0.938 . . . . 0.0 109.347 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.428 ' HA ' ' OE1' ' A' ' 11' ' ' GLN . 11.3 tp60 -92.07 38.55 1.0 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 12' ' ' VAL . 2.5 p -105.06 83.07 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.823 -0.548 . . . . 0.0 110.063 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 14' ' ' LEU . 3.3 mm-40 51.9 28.72 5.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.239 -0.913 . . . . 0.0 109.686 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.502 HD23 ' O ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -48.72 176.61 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.07 -1.019 . . . . 0.0 109.478 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.36 153.77 6.58 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.29 79.2 3.36 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.656 2.237 . . . . 0.0 110.465 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -159.84 -88.65 0.07 OUTLIER Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.42 -1.36 11.53 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.594 2.196 . . . . 0.0 110.126 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.74 177.01 7.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.93 . . . . 0.0 109.467 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -142.64 -161.62 8.88 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.274 -1.133 . . . . 0.0 109.585 179.87 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 121.245 0.545 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -93.85 -31.69 14.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.276 -0.89 . . . . 0.0 109.238 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 53.43 32.26 13.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.418 -0.801 . . . . 0.0 109.515 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.417 HD22 ' HA ' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -81.84 -70.64 0.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.614 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -79.28 4.66 14.45 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.1 -1.0 . . . . 0.0 109.573 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -88.32 40.29 0.95 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 12' ' ' VAL . 3.4 p -118.81 98.84 6.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.682 -0.636 . . . . 0.0 110.144 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 12' ' ' VAL . 0.3 OUTLIER 42.54 56.54 3.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.094 -1.004 . . . . 0.0 109.715 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 13' ' ' GLU . 4.9 mt -46.36 169.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.575 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -165.11 95.71 0.12 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.76 74.33 5.26 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.526 2.151 . . . . 0.0 110.719 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.14 74.76 1.28 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.37 -75.03 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.581 2.187 . . . . 0.0 110.156 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.02 -16.54 12.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.461 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -147.75 -179.51 23.81 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.312 -1.11 . . . . 0.0 109.601 -180.0 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtt . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.34 0.59 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.17 -69.78 2.07 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 1.0 OUTLIER -77.33 -27.61 52.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.235 -1.156 . . . . 0.0 109.599 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 3' ' ' LYS . . . 61.09 151.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.133 -0.979 . . . . 0.0 109.356 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -136.44 158.82 43.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -0.893 . . . . 0.0 109.516 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.494 ' HB3' ' HB2' ' A' ' 9' ' ' LEU . 3.6 t-20 -99.27 -176.94 3.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 109.58 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -92.26 -55.43 3.42 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.333 -0.854 . . . . 0.0 109.363 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -127.91 53.14 1.8 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.387 -0.821 . . . . 0.0 109.57 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.749 HD13 ' C ' ' A' ' 9' ' ' LEU . 3.5 tm? -88.97 -71.36 0.6 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.23 -0.919 . . . . 0.0 109.442 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.542 ' CD1' ' C ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -76.42 4.18 9.59 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.301 -0.874 . . . . 0.0 110.333 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.06 32.67 0.74 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.746 HG22 ' O ' ' A' ' 12' ' ' VAL . 2.3 p -105.95 68.95 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.698 -0.626 . . . . 0.0 109.524 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 49.74 55.77 8.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.329 -0.857 . . . . 0.0 109.429 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' A' ' 15' ' ' GLY . 0.8 OUTLIER -56.04 173.23 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.262 -0.899 . . . . 0.0 109.414 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.412 ' HA3' ' SD ' ' A' ' 22' ' ' MET . . . 55.29 100.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.91 78.49 3.55 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.425 2.083 . . . . 0.0 110.291 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -131.51 80.06 0.34 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.26 -81.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.671 2.247 . . . . 0.0 110.43 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.4 t -57.54 132.51 53.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.876 . . . . 0.0 109.612 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 66.95 -147.45 49.46 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.27 -174.9 2.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.305 -1.115 . . . . 0.0 109.517 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.656 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 5.7 ttt -110.99 156.46 21.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.37 -0.831 . . . . 0.0 109.419 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 22' ' ' MET . . . 167.67 67.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 0.0 109.517 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.43 16.47 24.46 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.901 . . . . 0.0 109.387 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.0 mptt 52.3 68.48 0.81 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.528 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 4.8 tpt -149.13 -60.14 0.22 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.167 -0.958 . . . . 0.0 109.312 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 77.4 p -124.91 91.15 3.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.507 -0.745 . . . . 0.0 109.229 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.65 81.02 1.38 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.217 -0.927 . . . . 0.0 109.686 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.22 57.28 1.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.38 -0.825 . . . . 0.0 109.259 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.508 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -67.12 -67.76 0.43 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.604 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 30' ' ' LYS . . . 174.93 74.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.324 -0.86 . . . . 0.0 109.483 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.73 -97.55 0.02 OUTLIER Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.8 ptt180 -98.49 -170.42 1.95 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -1.15 . . . . 0.0 109.443 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 CA-C-O 118.05 -1.417 . . . . 0.0 109.604 179.979 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.4 ttp . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.39 31.76 2.72 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt 58.6 63.93 1.57 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -1.144 . . . . 0.0 109.467 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -115.25 111.47 20.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.343 -0.848 . . . . 0.0 109.413 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.11 156.31 27.83 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.864 . . . . 0.0 109.426 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -133.48 -45.94 0.82 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.334 -0.854 . . . . 0.0 109.342 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -98.48 -25.76 14.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.458 -0.776 . . . . 0.0 109.408 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -91.3 47.23 1.37 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.14 -0.975 . . . . 0.0 109.576 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.7 tt -82.04 -19.93 39.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.161 -0.962 . . . . 0.0 109.439 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.409 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -80.92 6.6 12.8 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.228 -0.92 . . . . 0.0 109.504 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.42 34.7 0.95 Allowed 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.74 HG22 ' O ' ' A' ' 12' ' ' VAL . 2.2 p -101.54 71.29 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.832 -0.542 . . . . 0.0 109.603 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 14' ' ' LEU . 1.3 tt0 54.75 46.38 24.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.314 -0.866 . . . . 0.0 109.534 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.8 OUTLIER -46.15 171.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 109.336 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.09 137.76 41.09 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.29 78.97 3.43 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.436 2.09 . . . . 0.0 110.521 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.51 178.04 16.63 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.413 ' C ' ' OG ' ' A' ' 19' ' ' SER . 35.9 Cg_endo -78.6 -58.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.662 2.242 . . . . 0.0 110.408 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.413 ' OG ' ' C ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER 62.84 35.46 13.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.18 -0.95 . . . . 0.0 109.369 -179.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.84 -108.82 3.28 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.44 169.98 8.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.228 -1.16 . . . . 0.0 109.461 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.634 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 7.9 mtt -68.25 109.21 3.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.906 . . . . 0.0 109.407 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.634 ' HB2' ' O ' ' A' ' 22' ' ' MET . . . 168.48 83.54 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.279 -0.888 . . . . 0.0 109.458 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.09 151.3 19.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.413 ' O ' ' O ' ' A' ' 26' ' ' MET . 1.3 mttp -153.55 84.83 1.18 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.35 -0.844 . . . . 0.0 109.426 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.413 ' O ' ' O ' ' A' ' 25' ' ' LYS . 1.3 ttt 62.79 134.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.494 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.76 112.63 24.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.322 -0.861 . . . . 0.0 109.494 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.58 89.45 1.77 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.235 -0.916 . . . . 0.0 109.49 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.0 ttpp -172.08 -70.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 0.0 109.543 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -138.45 159.92 40.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.164 -0.96 . . . . 0.0 109.461 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 30' ' ' LYS . . . -48.66 176.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.282 -0.886 . . . . 0.0 109.538 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -123.46 -175.19 14.41 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -87.69 147.52 25.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.156 -1.203 . . . . 0.0 109.463 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 CA-C-O 117.94 -1.478 . . . . 0.0 109.568 -179.94 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 ttm . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.307 0.575 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.87 29.7 46.15 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.56 80.73 1.37 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -1.16 . . . . 0.0 109.644 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.53 117.98 28.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -0.929 . . . . 0.0 109.392 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -117.97 -49.71 2.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.137 -0.977 . . . . 0.0 109.571 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -58.66 150.74 22.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 109.527 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.28 -34.77 17.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.347 -0.846 . . . . 0.0 109.144 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.45 ' OE1' ' OE1' ' A' ' 11' ' ' GLN . 2.2 mt-10 -88.63 38.98 0.9 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.415 -0.803 . . . . 0.0 109.534 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.576 HD13 ' O ' ' A' ' 9' ' ' LEU . 0.4 OUTLIER -71.18 -58.48 3.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -0.946 . . . . 0.0 109.232 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.518 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -82.88 7.21 15.95 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.221 -0.925 . . . . 0.0 109.387 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.45 ' OE1' ' OE1' ' A' ' 8' ' ' GLU . 4.8 tt0 -89.86 36.94 0.86 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.155 -0.965 . . . . 0.0 108.415 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 12' ' ' VAL . 2.9 p -110.59 79.99 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.725 -0.609 . . . . 0.0 109.603 -179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 14' ' ' LEU . 1.1 tt0 50.11 71.23 0.42 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.083 -1.01 . . . . 0.0 108.821 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.519 ' HA ' HD13 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -42.27 161.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.339 -0.851 . . . . 0.0 109.71 -179.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.04 -67.07 0.04 OUTLIER Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.15 74.44 5.32 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.657 2.238 . . . . 0.0 110.255 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -96.75 155.27 20.79 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -80.58 42.87 1.41 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.775 2.317 . . . . 0.0 110.592 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.0 p -59.61 123.2 16.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 109.553 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.3 -141.34 6.24 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -104.46 99.4 9.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.255 -1.144 . . . . 0.0 109.466 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.567 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 0.6 OUTLIER -83.45 -58.57 2.77 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.164 -0.96 . . . . 0.0 109.532 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.665 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . 67.94 98.41 0.06 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.174 -0.953 . . . . 0.0 109.384 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 23' ' ' ALA . . . 72.91 173.53 0.3 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.196 -0.94 . . . . 0.0 109.47 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 67.17 96.19 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.932 . . . . 0.0 109.427 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 17.4 ttt -139.31 86.94 2.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.183 -0.948 . . . . 0.0 109.566 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 67.7 m -116.65 111.51 19.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.942 . . . . 0.0 109.406 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 27' ' ' SER . 2.5 mmmm 65.32 137.76 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.299 -0.875 . . . . 0.0 109.364 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.72 23.27 14.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.124 -0.985 . . . . 0.0 109.577 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -87.49 164.21 16.27 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.298 -0.876 . . . . 0.0 109.343 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.3 92.15 9.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.175 -0.953 . . . . 0.0 109.574 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.5 -170.58 20.43 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -178.9 134.04 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.209 -1.171 . . . . 0.0 109.498 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 CA-C-O 118.017 -1.435 . . . . 0.0 109.651 179.991 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -102.7 69.86 0.32 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.7 mmtp -73.77 -23.76 59.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.306 -1.114 . . . . 0.0 109.361 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.77 -173.03 3.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.451 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -93.25 98.06 11.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.414 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.38 169.17 8.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.225 -0.922 . . . . 0.0 109.539 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.509 ' N ' ' CD1' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -89.5 -63.87 1.22 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.279 -0.888 . . . . 0.0 109.423 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 7' ' ' TYR . 11.8 mt-10 64.12 65.25 0.69 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.435 -0.79 . . . . 0.0 109.391 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.492 ' O ' HD23 ' A' ' 9' ' ' LEU . 4.6 tt -120.19 -47.61 2.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.184 -0.947 . . . . 0.0 109.329 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.449 ' O ' ' HG ' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -84.34 10.82 9.6 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.276 -0.89 . . . . 0.0 109.268 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.97 32.89 0.88 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 12' ' ' VAL . 3.7 p -109.96 76.63 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 121.383 0.611 . . . . 0.0 109.457 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 51.93 63.6 2.18 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.119 -0.988 . . . . 0.0 109.284 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 14' ' ' LEU . 5.1 mt -45.64 165.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.351 -0.843 . . . . 0.0 109.659 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -52.2 -90.8 0.01 OUTLIER Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.61 -164.87 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.804 2.336 . . . . 0.0 110.45 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.407 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 151.36 -94.96 0.15 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.407 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 35.4 Cg_endo -77.85 -24.97 8.09 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.53 2.153 . . . . 0.0 110.507 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.01 -168.32 1.88 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.31 -0.869 . . . . 0.0 109.476 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 21' ' ' ASP . . . -68.09 -101.41 0.03 OUTLIER Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.502 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 15.8 t70 74.68 87.0 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -1.126 . . . . 0.0 109.545 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.52 -44.51 14.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.172 -0.955 . . . . 0.0 109.334 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -162.94 78.31 0.46 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.34 -0.85 . . . . 0.0 109.31 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.17 98.89 11.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.26 -0.9 . . . . 0.0 109.673 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.434 ' HE2' ' O ' ' A' ' 26' ' ' MET . 0.0 OUTLIER 56.92 69.46 0.74 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 0.0 109.551 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.434 ' O ' ' HE2' ' A' ' 25' ' ' LYS . 1.8 ttp -48.4 112.55 0.61 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.911 . . . . 0.0 109.436 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -143.62 142.11 30.9 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.354 -0.841 . . . . 0.0 109.444 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -154.31 128.61 9.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.284 -0.885 . . . . 0.0 109.542 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 64.11 119.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.249 -0.907 . . . . 0.0 109.646 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.1 -37.33 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.226 -0.922 . . . . 0.0 109.232 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.28 -34.79 14.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 109.295 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.11 174.74 29.46 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.74 42.04 1.22 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.253 -1.145 . . . . 0.0 109.609 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mtp . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 113.61 120.22 3.59 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.6 mttt 58.58 -177.38 0.08 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.204 -1.174 . . . . 0.0 109.616 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -141.73 -72.21 0.33 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.274 -0.891 . . . . 0.0 109.233 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -94.53 150.79 19.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 0.0 109.145 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 7' ' ' TYR . 0.9 OUTLIER -154.53 -49.84 0.09 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.096 -1.002 . . . . 0.0 109.774 -179.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.506 ' CE2' HG21 ' A' ' 12' ' ' VAL . 2.6 m-85 -40.81 165.48 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.243 -0.911 . . . . 0.0 110.712 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 7' ' ' TYR . 0.8 OUTLIER -157.04 -101.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.54 -0.725 . . . . 0.0 109.537 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.589 HD12 ' N ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -127.69 -131.22 0.23 Allowed 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.956 -1.09 . . . . 0.0 108.827 -179.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.589 ' N ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -68.01 -1.66 6.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.686 -1.259 . . . . 0.0 110.616 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.419 ' N ' ' HD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -91.49 32.01 1.11 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.792 -1.193 . . . . 0.0 108.166 179.19 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 9' ' ' LEU . 3.1 p -105.72 98.97 7.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 121.299 0.571 . . . . 0.0 109.78 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER 48.54 31.05 2.69 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.164 -0.96 . . . . 0.0 109.405 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -50.24 179.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.286 -0.884 . . . . 0.0 109.701 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -123.8 -76.45 0.32 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -76.87 80.48 2.82 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.652 2.234 . . . . 0.0 110.627 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -103.81 -149.77 20.76 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.06 -34.11 1.81 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.411 2.074 . . . . 0.0 110.087 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -122.24 165.87 15.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.366 -0.834 . . . . 0.0 109.189 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.43 -97.14 0.89 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -85.39 46.06 1.25 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -1.153 . . . . 0.0 109.893 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.93 144.24 57.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.939 . . . . 0.0 109.125 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -147.17 85.7 1.61 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.099 -1.0 . . . . 0.0 109.738 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -123.45 16.46 9.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.844 . . . . 0.0 109.439 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.46 ' HD2' ' O ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -165.07 76.46 0.28 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.847 . . . . 0.0 109.351 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -151.03 137.67 18.79 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.28 -0.887 . . . . 0.0 109.409 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.31 179.85 6.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.249 -0.907 . . . . 0.0 109.466 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.32 86.21 1.82 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.381 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.5 tptm -157.42 60.11 0.5 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 109.465 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.425 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -84.63 -22.37 29.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.218 -0.926 . . . . 0.0 109.341 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 30' ' ' LYS . . . 60.79 153.62 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.465 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.47 90.33 0.08 OUTLIER Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 47.99 24.49 0.63 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -1.131 . . . . 0.0 109.487 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.939 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.31 0.576 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.95 143.47 4.85 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -139.46 160.13 40.55 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.305 -1.114 . . . . 0.0 109.591 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -173.11 61.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.117 -0.989 . . . . 0.0 109.497 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -148.74 63.73 1.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.314 -0.866 . . . . 0.0 109.498 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -146.32 112.06 5.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -0.892 . . . . 0.0 109.525 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -96.03 -78.79 0.45 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.39 -0.819 . . . . 0.0 109.31 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 7' ' ' TYR . 18.2 mt-10 42.12 44.55 3.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 109.705 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.787 HD23 ' N ' ' A' ' 10' ' ' TYR . 10.2 tt -67.33 -86.25 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.416 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.787 ' N ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -74.88 3.72 7.7 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.912 -1.117 . . . . 0.0 110.531 -179.77 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.406 ' N ' ' HD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -93.58 32.63 1.36 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.019 -1.051 . . . . 0.0 108.187 179.139 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 12' ' ' VAL . 2.4 p -101.98 87.19 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.66 -0.65 . . . . 0.0 110.008 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 12' ' ' VAL . 16.4 mm-40 44.54 48.45 8.48 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.135 -0.978 . . . . 0.0 109.349 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 10' ' ' TYR . 1.7 mt -47.48 151.4 0.79 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.386 -0.821 . . . . 0.0 109.514 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -109.56 156.83 15.42 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.9 82.46 2.42 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.641 2.227 . . . . 0.0 110.491 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.91 167.12 22.4 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.49 -41.21 0.27 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.606 2.204 . . . . 0.0 110.452 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.7 t -84.21 149.55 26.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -0.85 . . . . 0.0 109.478 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.44 ' O ' ' O ' ' A' ' 21' ' ' ASP . . . -164.06 -162.83 15.7 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.44 ' O ' ' O ' ' A' ' 20' ' ' GLY . 8.3 m-20 60.95 122.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.254 -1.145 . . . . 0.0 109.45 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 5.9 mtp -95.62 83.44 3.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.49 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -121.41 62.48 0.91 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.375 -0.828 . . . . 0.0 109.41 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -171.68 -38.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 109.606 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -129.48 63.92 1.5 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -0.898 . . . . 0.0 109.62 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.4 ttt -102.15 172.9 6.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.206 -0.934 . . . . 0.0 109.354 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.17 179.81 6.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.256 -0.903 . . . . 0.0 109.729 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.74 100.22 13.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.31 -0.869 . . . . 0.0 109.532 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 29' ' ' LYS . 16.2 pttm -128.44 126.79 41.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.186 -0.946 . . . . 0.0 109.374 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' A' ' 32' ' ' GLY . 32.1 mmtp -105.82 -165.55 1.12 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.319 -0.863 . . . . 0.0 109.448 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.54 91.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.527 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 30' ' ' LYS . . . -132.26 160.46 23.68 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -138.34 109.17 6.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.223 -1.163 . . . . 0.0 109.476 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 CA-C-O 118.01 -1.439 . . . . 0.0 109.556 -179.847 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.252 0.549 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.62 -154.38 30.59 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -80.24 104.96 11.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -1.208 . . . . 0.0 109.441 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -157.69 152.55 25.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -0.891 . . . . 0.0 109.345 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.71 -65.49 0.98 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.158 -0.964 . . . . 0.0 109.603 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.522 ' O ' ' CB ' ' A' ' 11' ' ' GLN . 1.2 m120 -73.47 111.03 8.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 109.807 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.59 -30.46 16.36 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.178 -0.951 . . . . 0.0 109.137 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -113.3 15.63 19.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.326 -0.859 . . . . 0.0 109.879 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.664 HD23 ' H ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -104.84 -142.24 0.37 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.021 -1.049 . . . . 0.0 109.266 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.664 ' H ' HD23 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -65.0 -6.19 8.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.111 -0.993 . . . . 0.0 110.47 -179.553 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.522 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 1.0 OUTLIER -90.4 40.39 1.01 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.957 -1.089 . . . . 0.0 108.126 179.254 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.8 p -113.31 85.62 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.783 -0.573 . . . . 0.0 109.754 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER 45.44 75.77 0.1 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.005 -1.059 . . . . 0.0 108.951 -179.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 13' ' ' GLU . 3.4 mm? -44.2 169.07 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.362 -0.836 . . . . 0.0 109.689 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.01 176.6 23.97 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.48 86.66 1.64 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.612 2.208 . . . . 0.0 110.532 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 61.15 86.69 0.04 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.19 -70.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.617 2.211 . . . . 0.0 110.512 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.3 p -175.37 93.91 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.136 -0.978 . . . . 0.0 109.659 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 142.64 -132.92 5.32 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.2 p30 -83.83 178.05 8.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.203 -1.175 . . . . 0.0 109.528 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 6.6 ttm -143.05 -163.37 1.62 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 109.518 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 46.3 71.98 0.26 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 109.5 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -122.91 65.07 0.97 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.397 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.36 80.38 1.35 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.47 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.52 116.04 4.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.301 -0.875 . . . . 0.0 109.304 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.83 125.68 2.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.183 -0.948 . . . . 0.0 109.743 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -119.05 140.47 49.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.268 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -145.57 -49.93 0.24 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.093 -1.004 . . . . 0.0 109.717 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.616 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -172.48 74.82 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.172 -0.955 . . . . 0.0 109.559 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 30' ' ' LYS . . . 168.85 70.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.244 -0.91 . . . . 0.0 109.46 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.62 111.62 4.32 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -102.3 135.76 43.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -1.143 . . . . 0.0 109.463 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 CA-C-O 117.903 -1.498 . . . . 0.0 109.526 179.999 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.293 0.568 . . . . 0.0 109.571 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 154.05 -140.87 7.8 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -150.88 152.36 33.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -1.121 . . . . 0.0 109.368 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.55 112.34 5.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.331 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -75.68 82.3 2.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.547 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -113.15 -43.77 3.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.359 -0.838 . . . . 0.0 109.485 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -81.91 -66.74 0.85 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 109.23 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 45.89 72.52 0.22 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.485 -0.76 . . . . 0.0 109.453 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.535 HD23 ' H ' ' A' ' 10' ' ' TYR . 0.3 OUTLIER -96.47 -139.37 0.27 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.889 . . . . 0.0 109.147 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.535 ' H ' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -68.63 -2.67 9.6 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.942 -1.099 . . . . 0.0 110.499 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.478 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 0.9 OUTLIER -90.28 34.05 0.88 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.229 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 12' ' ' VAL . 3.4 p -103.77 78.02 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.355 0.597 . . . . 0.0 109.496 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.475 ' O ' ' O ' ' A' ' 14' ' ' LEU . 0.5 OUTLIER 56.41 64.99 1.53 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.074 -1.016 . . . . 0.0 108.816 -179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -48.52 -179.97 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.411 -0.805 . . . . 0.0 109.862 -179.542 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -169.48 94.68 0.11 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.03 86.79 1.64 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.638 2.225 . . . . 0.0 110.944 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.9 77.92 1.38 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.59 -63.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.692 2.261 . . . . 0.0 110.549 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.27 116.14 12.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.887 . . . . 0.0 109.903 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 61.34 179.37 2.99 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -129.33 54.69 1.8 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -1.142 . . . . 0.0 109.376 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.557 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -126.0 57.91 1.36 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 109.497 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 22' ' ' MET . . . 172.19 84.9 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.297 -0.877 . . . . 0.0 109.573 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -49.28 -59.03 4.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.196 -0.94 . . . . 0.0 109.265 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 50.71 79.01 0.09 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.292 -0.88 . . . . 0.0 109.655 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.418 ' O ' ' CB ' ' A' ' 27' ' ' SER . 7.1 mtt -133.79 168.95 17.8 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.327 -0.858 . . . . 0.0 109.401 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 0.5 OUTLIER 68.74 -178.63 0.22 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.277 -0.889 . . . . 0.0 109.361 -179.858 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 27' ' ' SER . 0.3 OUTLIER 69.18 163.83 0.24 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 109.479 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.93 166.29 22.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 0.0 109.519 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.51 67.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.9 . . . . 0.0 109.556 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.67 124.22 15.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.068 -1.02 . . . . 0.0 109.455 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.82 75.37 0.27 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -62.89 -58.95 5.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -1.148 . . . . 0.0 109.534 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 CA-C-O 117.933 -1.482 . . . . 0.0 109.554 179.945 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mtm . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.7 -179.74 29.83 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -102.66 70.74 1.14 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.357 -1.084 . . . . 0.0 109.422 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 5' ' ' GLU . . . -116.79 42.21 2.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.344 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 4' ' ' ALA . 1.7 mt-10 65.11 144.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.473 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -92.48 151.1 20.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -0.917 . . . . 0.0 109.441 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.591 ' N ' ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -93.04 -30.73 15.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 0.0 109.369 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 67.19 59.44 0.53 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.48 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 tt -71.28 -7.25 45.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.635 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -88.31 -5.08 58.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.18 -0.95 . . . . 0.0 109.399 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.66 41.06 1.02 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 12' ' ' VAL . 2.7 p -112.93 93.89 2.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.708 -0.62 . . . . 0.0 109.925 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 12' ' ' VAL . 8.6 tp10 44.47 51.38 7.87 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.11 -0.994 . . . . 0.0 109.248 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 10' ' ' TYR . 1.4 mt -55.7 -179.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.353 -0.842 . . . . 0.0 109.631 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.71 -64.42 0.17 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.27 81.38 2.64 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.646 2.231 . . . . 0.0 110.285 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.71 -173.6 7.05 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.32 -63.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.663 2.242 . . . . 0.0 110.495 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 71.2 p -125.36 24.35 7.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.262 -0.899 . . . . 0.0 109.572 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 165.56 -148.82 14.49 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.52 -64.94 0.66 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -1.146 . . . . 0.0 109.423 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.541 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 15.7 mtt -81.67 150.42 28.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.237 -0.914 . . . . 0.0 109.542 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 22' ' ' MET . . . 173.55 69.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.229 -0.92 . . . . 0.0 109.472 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 23' ' ' ALA . . . 64.71 109.74 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.291 -0.881 . . . . 0.0 109.521 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -170.01 60.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.178 -0.951 . . . . 0.0 109.512 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 1.8 tpp -152.44 123.06 7.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 0.0 109.304 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.3 t -144.41 143.64 31.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.195 -0.941 . . . . 0.0 109.729 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -137.19 119.12 15.27 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.279 -0.888 . . . . 0.0 109.231 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 30' ' ' LYS . 0.5 OUTLIER -61.85 -175.73 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.523 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -44.43 120.86 2.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.669 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -126.73 118.42 24.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.29 -0.882 . . . . 0.0 109.403 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.51 -118.7 0.02 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -42.47 78.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -1.139 . . . . 0.0 109.396 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 CA-C-O 117.967 -1.463 . . . . 0.0 109.596 -179.957 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.5 ptm . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.06 -140.83 21.1 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.584 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 1.5 pttt -158.83 68.84 0.46 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -1.185 . . . . 0.0 109.593 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 3' ' ' LYS . . . 69.14 -177.43 0.21 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 109.713 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 178.51 -156.42 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.264 -0.897 . . . . 0.0 109.317 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -149.7 -174.58 4.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 0.0 109.402 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.25 -67.64 0.77 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.139 -0.976 . . . . 0.0 109.431 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 52.4 74.87 0.25 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.397 -0.815 . . . . 0.0 109.207 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.462 ' O ' HG12 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -90.97 -145.52 0.19 Allowed 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.135 -0.978 . . . . 0.0 109.364 -179.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.513 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -70.59 -1.98 12.8 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.137 -0.977 . . . . 0.0 110.342 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.408 ' N ' ' HD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -94.14 31.6 1.65 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 12' ' ' VAL . 2.6 p -96.97 75.91 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 14' ' ' LEU . 1.0 OUTLIER 47.19 53.04 11.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.17 -0.956 . . . . 0.0 109.213 -179.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.534 ' CD2' ' N ' ' A' ' 14' ' ' LEU . 0.4 OUTLIER -48.26 178.13 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.392 -0.817 . . . . 0.0 110.004 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.2 -78.85 0.09 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -80.8 -165.33 0.33 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.731 2.287 . . . . 0.0 110.746 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -166.31 -156.28 9.4 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.66 -9.69 15.86 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.62 2.213 . . . . 0.0 110.48 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.49 -92.77 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 109.581 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 21' ' ' ASP . . . -104.78 -159.2 23.65 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 20' ' ' GLY . 1.6 m-20 69.46 128.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -1.131 . . . . 0.0 109.512 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.431 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 24.5 ttp -105.24 -44.32 4.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.18 -0.95 . . . . 0.0 109.47 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 22' ' ' MET . . . 61.54 60.3 1.69 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -0.849 . . . . 0.0 109.455 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -109.8 119.35 39.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.201 -0.937 . . . . 0.0 109.52 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 7.1 mmtp 66.05 72.8 0.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.292 -0.88 . . . . 0.0 109.524 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -159.44 127.27 4.88 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.303 -0.873 . . . . 0.0 109.277 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 6.5 m -130.1 176.65 7.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -0.982 . . . . 0.0 109.848 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 29' ' ' LYS . 4.3 mttt -149.44 175.59 11.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.359 -0.838 . . . . 0.0 109.131 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 28' ' ' LYS . 1.8 mtpt 61.32 125.55 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.141 -0.975 . . . . 0.0 109.527 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.29 38.35 0.86 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.27 -0.893 . . . . 0.0 109.404 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -111.77 20.97 16.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 109.467 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -157.58 -49.4 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.99 19.83 19.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.163 -1.198 . . . . 0.0 109.561 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 CA-C-O 117.914 -1.492 . . . . 0.0 109.483 -179.979 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 ttt . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.6 136.19 0.31 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.29 43.33 10.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -1.122 . . . . 0.0 109.441 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -114.54 39.05 2.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.156 -0.965 . . . . 0.0 109.418 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -124.06 139.12 54.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.266 -0.896 . . . . 0.0 109.447 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -121.25 162.6 19.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 109.57 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -86.1 -47.99 9.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.015 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.438 ' HA ' ' OE1' ' A' ' 8' ' ' GLU . 4.2 mm-40 -106.42 65.43 0.68 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.469 -0.769 . . . . 0.0 109.276 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.2 tt -86.04 8.98 18.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.282 -0.886 . . . . 0.0 109.493 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.548 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -87.41 -8.01 57.05 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.317 -0.864 . . . . 0.0 109.63 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.12 40.06 0.99 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 12' ' ' VAL . 2.2 p -106.63 75.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.392 0.615 . . . . 0.0 109.96 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 12' ' ' VAL . 60.7 mt-10 43.9 44.0 5.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.289 -0.882 . . . . 0.0 109.591 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 1.013 HD23 ' N ' ' A' ' 15' ' ' GLY . 5.2 tt -47.8 153.07 0.65 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.27 -0.894 . . . . 0.0 109.427 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 1.013 ' N ' HD23 ' A' ' 14' ' ' LEU . . . 165.6 168.32 27.59 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.3 81.27 2.78 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.758 2.305 . . . . 0.0 110.415 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.32 174.58 3.61 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.74 -3.16 13.28 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.549 2.166 . . . . 0.0 110.321 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.7 m -135.75 163.63 29.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.241 -0.912 . . . . 0.0 109.409 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 153.79 -151.99 23.65 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -94.44 163.28 13.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.274 -1.133 . . . . 0.0 109.351 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 3.2 ttt -137.27 36.01 2.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.306 -0.871 . . . . 0.0 109.502 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.45 60.29 1.7 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.268 -0.895 . . . . 0.0 109.409 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 25' ' ' LYS . . . -140.14 -41.75 0.43 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.35 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 26' ' ' MET . 1.8 ttpm? 44.74 75.29 0.11 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.874 . . . . 0.0 109.699 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.447 ' O ' ' O ' ' A' ' 25' ' ' LYS . 0.3 OUTLIER 57.32 111.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.255 -0.903 . . . . 0.0 109.654 179.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.9 p -115.67 90.24 3.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.351 -0.843 . . . . 0.0 109.223 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.3 tttt -74.06 135.87 43.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.897 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 mmtp 45.43 81.35 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.302 -0.874 . . . . 0.0 109.842 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -75.29 113.3 12.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.214 -0.929 . . . . 0.0 109.109 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -127.32 161.39 28.72 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.102 -0.999 . . . . 0.0 109.732 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 159.2 -161.24 31.9 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -127.99 86.74 2.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -1.193 . . . . 0.0 109.385 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 CA-C-O 117.974 -1.459 . . . . 0.0 109.535 179.974 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.483 ' O ' ' CB ' ' A' ' 3' ' ' LYS . . . 114.43 84.49 1.24 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER 73.25 43.29 0.39 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -1.146 . . . . 0.0 109.604 179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.14 109.18 14.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.58 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -160.76 50.12 0.26 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.529 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.515 ' HB2' HD12 ' A' ' 9' ' ' LEU . 1.3 t30 -94.62 -177.12 4.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.26 -0.9 . . . . 0.0 109.356 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.11 -51.21 4.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.12 -0.987 . . . . 0.0 109.852 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -94.54 25.68 3.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.289 -0.882 . . . . 0.0 109.998 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.515 HD12 ' HB2' ' A' ' 6' ' ' ASN . 1.6 tt -72.86 -48.99 32.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.072 -1.017 . . . . 0.0 109.351 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.689 ' O ' HD21 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -75.99 -5.52 46.69 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.279 -0.888 . . . . 0.0 109.757 -179.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -88.32 43.96 1.17 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.519 ' O ' HG13 ' A' ' 12' ' ' VAL . 3.5 p -116.96 78.85 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 121.376 0.608 . . . . 0.0 109.633 -178.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 50.37 74.66 0.21 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.106 -0.996 . . . . 0.0 109.14 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.689 HD21 ' O ' ' A' ' 10' ' ' TYR . 3.9 mm? -49.78 140.67 11.24 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.294 -0.879 . . . . 0.0 109.395 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 124.04 -94.64 0.49 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.54 75.27 5.04 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.651 2.234 . . . . 0.0 110.51 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -94.72 -157.32 32.61 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.4 -19.16 11.91 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.61 2.206 . . . . 0.0 110.419 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.9 p -102.24 80.18 1.94 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.286 -0.884 . . . . 0.0 109.457 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -156.56 -64.65 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 38.3 p-10 -64.41 98.8 0.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -1.091 . . . . 0.0 109.54 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.449 ' O ' ' HB2' ' A' ' 23' ' ' ALA . 0.6 OUTLIER -62.99 162.99 10.46 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.215 -0.928 . . . . 0.0 109.419 -179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 22' ' ' MET . . . 177.87 97.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 0.0 109.461 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.27 86.59 5.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.325 -0.859 . . . . 0.0 109.679 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt 54.17 76.18 0.25 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -0.886 . . . . 0.0 109.538 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 21.0 mtp -108.85 -168.59 1.36 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.41 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.9 m 49.31 74.98 0.17 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.327 -0.858 . . . . 0.0 109.512 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 ttpt -107.77 83.34 1.78 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.276 -0.89 . . . . 0.0 109.287 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.04 -95.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 0.0 109.488 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -153.15 -64.37 0.15 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.062 -1.024 . . . . 0.0 109.519 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -133.19 -73.1 0.5 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 0.0 109.649 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.89 49.43 3.12 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.64 88.83 3.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -1.126 . . . . 0.0 109.575 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.993 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ptt? . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.366 0.603 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -124.95 -177.87 15.08 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.407 ' O ' ' HG2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -53.68 140.69 28.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -1.15 . . . . 0.0 109.524 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -169.44 160.81 9.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.249 -0.907 . . . . 0.0 109.361 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -94.13 -21.18 19.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 109.509 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.418 ' OD1' ' HG2' ' A' ' 8' ' ' GLU . 21.6 t-20 -73.16 130.78 41.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 109.33 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.405 ' O ' ' C ' ' A' ' 8' ' ' GLU . 0.1 OUTLIER -77.73 -46.03 22.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.151 -0.968 . . . . 0.0 108.786 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.418 ' HG2' ' OD1' ' A' ' 6' ' ' ASN . 0.2 OUTLIER 45.28 36.17 2.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.404 -0.81 . . . . 0.0 109.361 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.458 ' HB3' ' CD1' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -103.97 -58.52 1.87 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.188 -0.945 . . . . 0.0 109.457 -179.859 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.591 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -84.62 -3.13 58.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.922 . . . . 0.0 109.558 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -90.0 42.58 1.1 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 12' ' ' VAL . 3.4 p -114.38 70.31 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.735 -0.603 . . . . 0.0 110.055 -178.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 53.45 61.68 3.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.159 -0.963 . . . . 0.0 109.544 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.512 ' CD1' ' O ' ' A' ' 10' ' ' TYR . 10.3 mt -66.49 175.19 2.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.342 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.81 152.04 36.26 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.38 80.15 2.98 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.642 2.228 . . . . 0.0 110.442 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.34 169.8 54.6 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.89 -65.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.617 2.212 . . . . 0.0 110.382 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.5 m -142.24 139.61 32.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.202 -0.936 . . . . 0.0 109.47 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 117.5 -148.57 18.72 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.498 ' O ' ' CG ' ' A' ' 22' ' ' MET . 0.9 OUTLIER 60.86 31.51 20.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -1.137 . . . . 0.0 109.409 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.498 ' CG ' ' O ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER 171.94 158.69 0.1 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 109.263 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 53.93 82.49 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.185 -0.947 . . . . 0.0 109.396 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.72 -158.79 0.21 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -0.893 . . . . 0.0 109.709 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.71 58.84 5.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.284 -0.885 . . . . 0.0 109.464 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -179.41 -170.35 0.17 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.889 . . . . 0.0 109.42 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 65.93 128.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.195 -0.94 . . . . 0.0 109.387 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 67.0 59.17 0.55 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.315 -0.866 . . . . 0.0 109.568 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.13 153.78 43.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.327 -0.858 . . . . 0.0 109.339 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.58 154.74 31.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.155 -0.966 . . . . 0.0 109.394 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.49 110.91 10.26 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.314 -0.866 . . . . 0.0 109.479 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.76 -152.04 11.95 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.57 -71.31 0.37 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.227 -1.161 . . . . 0.0 109.417 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 CA-C-O 117.985 -1.453 . . . . 0.0 109.469 -179.952 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.313 0.577 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -112.28 46.61 1.15 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 4' ' ' ALA . 1.1 mttm -121.93 45.15 2.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -1.163 . . . . 0.0 109.302 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 3' ' ' LYS . . . 44.51 87.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.278 -0.889 . . . . 0.0 109.397 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -158.33 145.31 17.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.244 -0.91 . . . . 0.0 109.536 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -143.77 154.98 44.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.388 -0.82 . . . . 0.0 109.371 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -100.72 -30.56 11.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.195 -0.941 . . . . 0.0 109.658 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.4 8.89 17.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.191 -0.943 . . . . 0.0 109.982 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 tt -67.17 -31.74 72.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.013 -1.055 . . . . 0.0 109.292 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.44 6.31 23.87 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.199 -0.938 . . . . 0.0 109.347 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.428 ' HA ' ' OE1' ' A' ' 11' ' ' GLN . 11.3 tp60 -92.07 38.55 1.0 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 12' ' ' VAL . 2.5 p -105.06 83.07 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.823 -0.548 . . . . 0.0 110.063 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.452 ' O ' ' O ' ' A' ' 14' ' ' LEU . 3.3 mm-40 51.9 28.72 5.35 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.239 -0.913 . . . . 0.0 109.686 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.502 HD23 ' O ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -48.72 176.61 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.07 -1.019 . . . . 0.0 109.478 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.36 153.77 6.58 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.29 79.2 3.36 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.656 2.237 . . . . 0.0 110.465 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -159.84 -88.65 0.07 OUTLIER Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.42 -1.36 11.53 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.594 2.196 . . . . 0.0 110.126 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -132.74 177.01 7.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -0.93 . . . . 0.0 109.467 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -142.64 -161.62 8.88 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -147.24 -46.16 0.17 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.274 -1.133 . . . . 0.0 109.585 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.83 98.93 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.227 -0.921 . . . . 0.0 109.337 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -170.06 89.25 0.16 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.191 -0.943 . . . . 0.0 109.655 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 58.6 105.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.626 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -157.08 77.41 0.87 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.295 -0.878 . . . . 0.0 109.348 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -179.79 77.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.314 -0.866 . . . . 0.0 109.309 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 28' ' ' LYS . 2.2 m -138.71 59.96 1.61 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.197 -0.939 . . . . 0.0 109.503 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.453 ' O ' ' O ' ' A' ' 27' ' ' SER . 9.5 tttt 52.94 173.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.272 -0.893 . . . . 0.0 109.608 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.452 ' O ' ' O ' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -102.65 -14.31 16.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 109.555 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.456 ' O ' ' O ' ' A' ' 31' ' ' ALA . 1.4 ttmt 56.7 107.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.259 -0.901 . . . . 0.0 109.445 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 30' ' ' LYS . . . 61.15 137.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.266 -0.896 . . . . 0.0 109.479 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.12 37.66 3.26 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.07 27.25 2.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.281 -1.129 . . . . 0.0 109.471 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 CA-C-O 118.014 -1.437 . . . . 0.0 109.602 -179.972 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 148.19 104.6 0.35 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.5 pttt -145.21 141.37 28.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.211 -1.17 . . . . 0.0 109.415 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.52 72.77 1.49 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.448 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.54 140.35 26.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -70.8 146.6 49.64 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.278 -0.889 . . . . 0.0 109.683 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -93.85 -31.69 14.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.276 -0.89 . . . . 0.0 109.238 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 53.43 32.26 13.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.418 -0.801 . . . . 0.0 109.515 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.417 HD22 ' HA ' ' A' ' 9' ' ' LEU . 0.1 OUTLIER -81.84 -70.64 0.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.512 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.614 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -79.28 4.66 14.45 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.1 -1.0 . . . . 0.0 109.573 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -88.32 40.29 0.95 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 12' ' ' VAL . 3.4 p -118.81 98.84 6.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.682 -0.636 . . . . 0.0 110.144 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 12' ' ' VAL . 0.3 OUTLIER 42.54 56.54 3.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.094 -1.004 . . . . 0.0 109.715 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 13' ' ' GLU . 4.9 mt -46.36 169.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.575 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -165.11 95.71 0.12 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.76 74.33 5.26 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.526 2.151 . . . . 0.0 110.719 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 93.14 74.76 1.28 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.37 -75.03 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.581 2.187 . . . . 0.0 110.156 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.02 -16.54 12.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 109.461 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -147.75 -179.51 23.81 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 61.98 150.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.312 -1.11 . . . . 0.0 109.601 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.17 -67.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.572 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -171.93 72.53 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.187 -0.946 . . . . 0.0 109.477 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' A' ' 25' ' ' LYS . . . -129.12 113.85 15.61 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.3 -0.875 . . . . 0.0 109.576 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 24' ' ' ALA . 1.8 tmmt? 65.63 82.5 0.18 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.194 -0.941 . . . . 0.0 109.551 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.448 ' O ' ' HB3' ' A' ' 27' ' ' SER . 1.7 ttp -152.72 -44.3 0.1 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.199 -0.938 . . . . 0.0 109.392 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 26' ' ' MET . 68.7 p 174.95 165.43 0.27 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.409 -0.807 . . . . 0.0 109.302 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.39 115.82 13.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.227 -0.92 . . . . 0.0 109.689 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -141.33 164.77 29.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -0.829 . . . . 0.0 109.382 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt -107.62 59.36 0.62 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.172 -0.955 . . . . 0.0 109.521 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -85.29 153.09 22.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.218 -0.926 . . . . 0.0 109.404 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.66 151.97 28.4 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.58 154.24 17.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -1.124 . . . . 0.0 109.442 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 CA-C-O 118.049 -1.417 . . . . 0.0 109.563 -179.928 . . . . . . . . 0 0 . 1 stop_ save_